aidx;assay_category;assay_cell_type;assay_chembl_id;assay_classifications;assay_organism;assay_parameters;assay_strain;assay_subcellular_fraction;assay_tax_id;assay_test_type;assay_tissue;assay_type;assay_type_description;bao_format;bao_label;cell_chembl_id;confidence_description;confidence_score;description;document_chembl_id;relationship_description;relationship_type;src_assay_id;src_id;target_chembl_id;tissue_chembl_id;variant_sequence
CLD0;;A498;CHEMBL619959;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308425;Target assigned is non-molecular;1;Cytotoxicity against A 498 tumor cell line;CHEMBL1132544;Non-molecular target assigned;N;;1;CHEMBL614516;;
CLD0;;A204;CHEMBL618619;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308354;Target assigned is non-molecular;1;Antiproliferative activity of compound was tested against rhabdomyosarcoma (A-204) human tumor cells;CHEMBL1128100;Non-molecular target assigned;N;;1;CHEMBL614514;;
CLD0;;A498;CHEMBL884012;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308425;Target assigned is non-molecular;1;Antiproliferative activity of compound was tested against renal cancer (A-498) human tumor cells;CHEMBL1128100;Non-molecular target assigned;N;;1;CHEMBL614516;;
CLD0;;;CHEMBL628290;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Calculated membrane partition coefficient (Kmemb);CHEMBL1149124;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL636076;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Tested for the partition coefficient between water and n-octanol.;CHEMBL1124930;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL634454;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Compound was evaluated for the change in Tm of isolated helical DNA in solution.;CHEMBL1123251;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL635477;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logD7.4);CHEMBL1124835;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL858438;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (log P) was the log of ratio of concentration in octanol / water partitioned concentration in phosphate buffer at pH 7.4.;CHEMBL1122652;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL633732;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient in octanol-phosphate buffer at pH 7.4;CHEMBL1123251;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL633721;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logP);CHEMBL1122587;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL635338;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;DNA binding dissociation constant as KD;CHEMBL1122633;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;OCI-AML2;CHEMBL641182;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308300;Target assigned is non-molecular;1;Cytotoxic activity against D100 daunorubicin (100 nM) resistant AML-2 cell line was determined;CHEMBL1136495;Non-molecular target assigned;N;;1;CHEMBL2366220;;
CLD0;;OCI-AML2;CHEMBL641183;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308300;Target assigned is non-molecular;1;Cytotoxic activity against DX-100: doxorubicin (100 ng/mL) resistant AML-2 cell line was determined;CHEMBL1136495;Non-molecular target assigned;N;;1;CHEMBL2366220;;
CLD0;;OCI-AML2;CHEMBL641184;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308300;Target assigned is non-molecular;1;Cytotoxic activity against wild type AML-2 leukemia cell line was determined;CHEMBL1136495;Non-molecular target assigned;N;;1;CHEMBL2366220;;
CLD0;;B16;CHEMBL650334;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308454;Target assigned is non-molecular;1;In vitro antiproliferative activity against B16 cell lines;CHEMBL1130292;Non-molecular target assigned;N;;1;CHEMBL381;;
CLD0;;B16;CHEMBL883253;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308454;Target assigned is non-molecular;1;Cytotoxicity that caused a 50% reduction in absorbance at 490 nm in B16 mouse melanoma cells using MTS assay.;CHEMBL1133679;Non-molecular target assigned;N;;1;CHEMBL381;;
CLD0;;;CHEMBL651225;[];Bacillus cereus;[];;;1396.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for antibacterial activity against Bacillus cereus WSU-60;CHEMBL1123433;Non-molecular target assigned;N;;1;CHEMBL613070;;
CLD0;;;CHEMBL650278;[];Bacillus subtilis;[];;;1423.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Compound was tested for its lambda-phage induction activity against Bacillus subtilis in a disk plate assay at concentration of dose of 0.8 ug/mL; Active";CHEMBL1121563;Non-molecular target assigned;N;;1;CHEMBL359;;
CLD0;;;CHEMBL650410;[];Bacillus subtilis;[];;;1423.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for antibacterial activity against Bacillus subtilis ATCC E6051;CHEMBL1123433;Non-molecular target assigned;N;;1;CHEMBL359;;
CLD0;;CCRF-CEM;CHEMBL653319;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;In vitro growth inhibitory activity against CCRF-CEM (human lymphoblastic leukemic) cells.;CHEMBL1122048;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL655115;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Inhibitory activity against CCRF-CEM(human leukemic lymphoblastic) cells in culture.;CHEMBL1122143;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL655021;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Effect on cross resistance of CCRF-CEM cells resistant to vincristine.;CHEMBL1124835;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CHO;CHEMBL653981;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against CHO cell line (Chinese hamster ovary) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL613853;;
CLD0;;CHO;CHEMBL653982;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against CHO cell line (Chinese hamster ovary) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL613853;;
CLD0;;CHO;CHEMBL876078;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Effect on cross resistance of CHO cells resistant to colchicine (CHRC5);CHEMBL1124835;Non-molecular target assigned;N;;1;CHEMBL613853;;
CLD0;;;CHEMBL656151;[];Bos taurus;[];;;9913.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Thermal denaturation temperature (Tm) of isolated calf thymus helical DNA was measured;CHEMBL1122183;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;CAPAN-1;CHEMBL656158;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307640;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against Capan-1 cell line (pancreatic carcinoma) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614536;;
CLD0;;CAPAN-1;CHEMBL656320;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307640;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against Capen-1 cell line (pancreatic carcinoma) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614536;;
CLD0;;;CHEMBL658165;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Tested for the cytotoxicity(1 hour incubation) against human colon tumor cell lines colon 4).;CHEMBL1124930;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL658166;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Tested for the cytotoxicity (continuous incubation) against human colon tumor cell lines (colon 4)determined by clonogenic assay.;CHEMBL1124930;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL662299;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Effect on cross resistance of chinese hamster cells resistant to Actinomycin D.;CHEMBL1124835;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL662786;[];Clostridium histolyticum;[];;;1498.0;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibitory concentration against Clostridium histolyticum Collagenase;CHEMBL1126272;Homologous protein target assigned;H;;1;CHEMBL333;;
CLD0;;;CHEMBL664992;[];Corynebacterium diphtheriae;[];;;1717.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for antibacterial activity against Corynebacterium diphtheria WSU;CHEMBL1123433;Non-molecular target assigned;N;;1;CHEMBL612638;;
CLD0;;;CHEMBL661369;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Tested for the binding affinity for DNA by intercalation between adjacent base pairs of the helix.;CHEMBL1124930;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL665560;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;"Binding affinity to Calf thymus DNA type XV; value ranges from 4E6 - 6E6 M-1";CHEMBL1151523;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;L1210;CHEMBL662947;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is molecular non-protein target;3;Inhibition of [3H]thymidine incorporation into proliferating L1210 cells.;CHEMBL1122652;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL662954;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Tested for binding affinity per DNA base pair in rat;CHEMBL1123433;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL664952;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Change in thermal denaturation temperature of calf thymus DNA;CHEMBL1122652;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;L5178Y;CHEMBL669614;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307690;Homologous single protein target assigned;8;Inhibitory activity against dihydrofolate reductase (DHFR) isolated from murine L5178Y tumor cells resistant and sensitive to methotrexate;CHEMBL1122587;Homologous protein target assigned;H;;1;CHEMBL4564;;
CLD0;;MES-SA/Dx5;CHEMBL673517;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308373;Target assigned is non-molecular;1;The compound was evaluated for the growth inhibition of Dx5 cell lines using MTT assay.;CHEMBL1133378;Non-molecular target assigned;N;;1;CHEMBL613827;;
CLD0;;MES-SA/Dx5;CHEMBL673518;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308373;Target assigned is non-molecular;1;The compound was evaluated for the growth inhibition of Dx5 w/PSC cell lines using MTT assay.;CHEMBL1133378;Non-molecular target assigned;N;;1;CHEMBL613827;;
CLD0;;EVSA-T;CHEMBL678201;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307361;Target assigned is non-molecular;1;Cytotoxicity against EVSA-T tumor cell line;CHEMBL1132544;Non-molecular target assigned;N;;1;CHEMBL614295;;
CLD0;;EVSA-T;CHEMBL678203;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307361;Target assigned is non-molecular;1;Antiproliferative activity of compound was tested against mammary carcinoma (EVSAT) human tumor cells;CHEMBL1128100;Non-molecular target assigned;N;;1;CHEMBL614295;;
CLD0;;;CHEMBL681208;[];Escherichia coli;[];;;562.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound is evaluated for lambda-phage induction activity in Escherichia coli (dose at 0.8 ug/mL);CHEMBL1121563;Non-molecular target assigned;N;;1;CHEMBL354;;
CLD0;;;CHEMBL681209;[];Escherichia coli;[];;;562.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound is evaluated for lambda-phage induction activity in Escherichia coli (dose at 1.6 ug/mL);CHEMBL1121563;Non-molecular target assigned;N;;1;CHEMBL354;;
CLD0;;;CHEMBL681212;[];Escherichia coli;[];;;562.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound is evaluated for lambda-phage induction activity in Escherichia coli (dose at 3.1 ug/mL);CHEMBL1121563;Non-molecular target assigned;N;;1;CHEMBL354;;
CLD0;;;CHEMBL681215;[];Escherichia coli;[];;;562.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Compound is evaluated for lambda-phage induction activity in Escherichia coli (dose at 6.2 ug/mL); Toxic to culture";CHEMBL1121563;Non-molecular target assigned;N;;1;CHEMBL354;;
CLD0;;;CHEMBL681584;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;"In vitro antiproliferative activity against Fibroblasts; not determined";CHEMBL1130292;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL691416;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Cytotoxicity against M19 tumor cell line;CHEMBL1132544;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL688082;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against HL-60 cell line (promyelocytic leukemia) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL688083;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against HL-60 cell line (promyelocytic leukemia) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL689641;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;In vitro concentration required to induce apoptosis in HL60 cells;CHEMBL1144989;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL689647;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;In vitro inhibitory concentration against proliferation of HL60 cells;CHEMBL1144989;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL687002;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;In vitro concentration required to induce apoptosis in HL60R cells;CHEMBL1144989;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL690289;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;In vitro inhibitory concentration against proliferation of HL60R cells;CHEMBL1144989;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL690290;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;In vitro inhibitory concentration against proliferation of HL60R cells along with 5 (uM) verapamil;CHEMBL1144989;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HMEC;CHEMBL690451;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307693;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against HMEC cell line (human mamm epithelial cells) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614734;;
CLD0;;HMEC;CHEMBL690452;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307693;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against HMEC cell line (human mamm epithelial cells) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614734;;
CLD0;;HT-29;CHEMBL692226;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against HT-29 cell line (colon carcinoma) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL692227;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against HT-29 cell line (colon carcinoma) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL693877;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Tested for the cytotoxicity(1 hour incubation) against human colon tumor cell lines (HT 29).;CHEMBL1124930;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL691584;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Tested for the cytotoxicity (continuous incubation) against human colon tumor cell lines (HT 29) determined by clonogenic assay.;CHEMBL1124930;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HTB-81;CHEMBL691298;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity that caused a 50% reduction in absorbance at 490 nm in human prostate cancer HTB-81 cells using MTS assay.;CHEMBL1133679;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;IGR-37 cell line;CHEMBL694792;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308435;Target assigned is non-molecular;1;Antiproliferative activity of compound was tested against melanoma (IgR-37) human tumor cells;CHEMBL1128100;Non-molecular target assigned;N;;1;CHEMBL613985;;
CLD0;;IGROV-1;CHEMBL701519;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;Antiproliferative activity of compound was tested against ovarian carcinoma (IGROV) human tumor cells;CHEMBL1128100;Non-molecular target assigned;N;;1;CHEMBL613984;;
CLD0;;IGROV-1;CHEMBL879051;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;Cytotoxicity against IGROV tumor cell line;CHEMBL1132544;Non-molecular target assigned;N;;1;CHEMBL613984;;
CLD0;;KB 3-1;CHEMBL701770;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307659;Target assigned is non-molecular;1;In vitro cytotoxicity using human epidermoid carcinoma (KB-3-1) cells;CHEMBL1129201;Non-molecular target assigned;N;;1;CHEMBL614590;;
CLD0;;KB 3-1;CHEMBL873095;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307659;Target assigned is non-molecular;1;In vitro cytotoxic activity was evaluated using the human epidermoid carcinoma cell line KB-3-1;CHEMBL1134999;Non-molecular target assigned;N;;1;CHEMBL614590;;
CLD0;;KB ;CHEMBL705343;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;In vitro cytotoxicity using human epidermoid carcinoma (KB-A1) cells;CHEMBL1129201;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB ;CHEMBL705344;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;In vitro cytotoxic activity was evaluated using the KB-3-1 resistant to adriamycin (ADR) subline KB-A1;CHEMBL1134999;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;L1210 (1565);CHEMBL702593;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307841;Target assigned is non-molecular;1;Cytotoxic activity against L-1210 parental cell line;CHEMBL1128855;Non-molecular target assigned;N;;1;CHEMBL614000;;
CLD0;;L1210 (1565);CHEMBL702594;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307841;Target assigned is non-molecular;1;Cytotoxic activity against adriamycin (ADR) resistant L-1210 cell line;CHEMBL1128855;Non-molecular target assigned;N;;1;CHEMBL614000;;
CLD0;;L1210 (1565);CHEMBL704011;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307841;Target assigned is non-molecular;1;Antitumor activity against L-1210 leukemia cell line in BDF1 mice after injecting 0.5 mg/kg intraperitoneal dose;CHEMBL1125096;Non-molecular target assigned;N;;1;CHEMBL614000;;
CLD0;;L1210 (1565);CHEMBL704012;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307841;Target assigned is non-molecular;1;Antitumor activity against L-1210 leukemia cell line in BDF1 mice after injecting 0.5 mg/kg ip dose;CHEMBL1124896;Non-molecular target assigned;N;;1;CHEMBL614000;;
CLD0;;KB ;CHEMBL702384;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Resistance factor (RF), ratio between the IC50 on the resistant cells and the IC50 on the corresponding sensitive cells of KB cell line;CHEMBL1134999;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;L1210;CHEMBL703251;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Dose required to inhibit the DNA synthesis in leukemia L1210 cells;CHEMBL1121844;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703252;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Dose required to inhibit the RNA synthesis in leukemia L1210 cells;CHEMBL1121844;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705937;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Compound was evaluated for the 50% inhibition of the incorporation of [3H]- thymidine in the DNA (inhibition of synthesis in leukemia L1210 cells);CHEMBL1123251;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705938;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Compound was evaluated for the 50% inhibition of the incorporation of [3H]- thymidine in the RNA (inhibition of synthesis in leukemia L1210 cells);CHEMBL1123251;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL879955;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Concentration of drug necessary to reduce by 50% the incorporation of tritiated thymidine in the DNA of actively growing L1210 cells;CHEMBL1122183;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705941;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Concentration of drug necessary to reduce by 50% the incorporation of tritiated uridine in the RNA of actively growing L1210 cells.;CHEMBL1122183;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL708939;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro cytotoxicity using murine leukemia L1210 cells from american type culture collection.;CHEMBL1129201;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL706240;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro cytotoxic activity was evaluated using the murine leukemia L1210 cell line;CHEMBL1134999;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704750;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibitory activity was measured against murine L1210 leukemia cells.;CHEMBL1131092;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;LXFL 529/11;CHEMBL706992;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307851;Target assigned is non-molecular;1;Tested for its inhibitory activity against xenograft (LXFL 529/11, lung, large cell) using a clonogenic assay;CHEMBL1150981;Non-molecular target assigned;N;;1;CHEMBL614017;;
CLD0;;L1210;CHEMBL706689;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Compound was evaluated for cytotoxicity against L1210 murine leukemia cells;CHEMBL1126457;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL854754;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Tested for the cytotoxicity(1 hour incubation) against L1210 leukemia cells.;CHEMBL1124930;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL712035;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Tested for the cytotoxicity (continuous incubation) against L1210 leukemia cells determined by clonogenic assay.;CHEMBL1124930;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;NCI-H226;CHEMBL703459;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307697;Target assigned is non-molecular;1;Cytotoxicity against H 226 tumor cell line;CHEMBL1132544;Non-molecular target assigned;N;;1;CHEMBL614740;;
CLD0;;MCF7;CHEMBL707772;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;compound was tested in vitro for inhibition activity against a sensitive human breast carcinoma line cells.;CHEMBL1130103;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL705281;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against MCF-7 tumor cell line;CHEMBL1132544;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;NCI/ADR-RES;CHEMBL712021;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;Compound was tested for its toxicity against doxorubicin resistant human breast cancer cells (MCF-7/ADR).;CHEMBL1131304;Non-molecular target assigned;N;;1;CHEMBL613829;;
CLD0;;NCI/ADR-RES;CHEMBL712028;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;compound was tested in vitro for inhibition activity against doxorubicin resistant counterpart of human breast carcinoma line cells.;CHEMBL1130103;Non-molecular target assigned;N;;1;CHEMBL613829;;
CLD0;;Lewis lung carcinoma cell line;CHEMBL711225;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307859;Target assigned is non-molecular;1;In vitro antiproliferative activity against Lewis cell lines;CHEMBL1130292;Non-molecular target assigned;N;;1;CHEMBL614088;;
CLD0;;M19-MEL;CHEMBL708482;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307506;Target assigned is non-molecular;1;Antiproliferative activity of compound was tested against melanoma (M-19) human tumor cells;CHEMBL1128100;Non-molecular target assigned;N;;1;CHEMBL614019;;
CLD0;;MCF7;CHEMBL709124;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity of compound was tested against mammary carcinoma (MCF-7) human tumor cells;CHEMBL1128100;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL709131;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Evaluated in vitro for antiproliferative activity against MCF-7 cell lines model of hormone dependent breast cancer;CHEMBL1130292;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL710203;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Compound was tested for its toxicity against human breast cancer cells(MCF-7);CHEMBL1131304;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL711353;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against MCF-7 cell line (breast carcinoma) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL711354;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against MCF-7 cell line (breast carcinoma) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;M109;CHEMBL713477;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307527;Target assigned is non-molecular;1;In vivo screening in M109 syngeneic solid mouse tumor model (i.p.);CHEMBL1133092;Non-molecular target assigned;N;;1;CHEMBL614073;;
CLD0;;M109;CHEMBL713478;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307527;Target assigned is non-molecular;1;In vivo screening in M109 syngeneic solid mouse tumor model (i.v.);CHEMBL1133092;Non-molecular target assigned;N;;1;CHEMBL614073;;
CLD0;;MDA-MB-361;CHEMBL874167;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308405;Target assigned is non-molecular;1;The compound was tested for extracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) in the presence of stCPG2 prodrug;CHEMBL1132269;Non-molecular target assigned;N;;1;CHEMBL614129;;
CLD0;;MDA-MB-361;CHEMBL711758;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308405;Target assigned is non-molecular;1;The compound was tested for intracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) expressing LacZ (beta-galactosidase).;CHEMBL1132269;Non-molecular target assigned;N;;1;CHEMBL614129;;
CLD0;;MDA-MB-361;CHEMBL711760;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308405;Target assigned is non-molecular;1;The compound was tested for intracellular cytotoxicity against MDA MB 361(mammary carcinoma cell line) in the presence of CPG2 prodrug;CHEMBL1132269;Non-molecular target assigned;N;;1;CHEMBL614129;;
CLD0;;MEXF989;CHEMBL714046;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307600;Target assigned is non-molecular;1;Tested for its inhibitory activity against human melanoma cells (MEFX 989) using a clonogenic assay at 0.01-1.0 uM;CHEMBL1150981;Non-molecular target assigned;N;;1;CHEMBL614344;;
CLD0;;SK-MES-1;CHEMBL710063;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307450;Target assigned is non-molecular;1;Resistance factor (RF), ratio between the IC50 on the resistant cells and the IC50 on the corresponding sensitive cells of MES cell line;CHEMBL1134999;Non-molecular target assigned;N;;1;CHEMBL614923;;
CLD0;;MES-SA ;CHEMBL872678;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;In vitro cytotoxic activity was evaluated using the human uterine sarcoma cell line MES-SA;CHEMBL1134999;Non-molecular target assigned;N;;1;CHEMBL614343;;
CLD0;;MES-SA ;CHEMBL713911;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;The compound was evaluated for the growth inhibition of MES-SA uterine tumor cell lines using MTT assay.;CHEMBL1133378;Non-molecular target assigned;N;;1;CHEMBL614343;;
CLD0;;MES-SA ;CHEMBL713919;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;In vitro cytotoxic activity was evaluated using the MES-SA multidrug-resistant subline MES-SA/Dx5;CHEMBL1134999;Non-molecular target assigned;N;;1;CHEMBL614343;;
CLD0;;;CHEMBL716675;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;Colon;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Number of mice(with Colon 38 tumors) cured after treatment of 3.9 mg/kg/day dose given as 3 times in a day for 4 days out of 5 mice;CHEMBL1136718;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3638202;
CLD0;;;CHEMBL719874;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 12 at 10 mg/kg/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL719875;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 12 at 11 mg/kg/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL719876;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 12 at 12(mg/kg)/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL719881;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 8 at 10 mg/kg/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL719882;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 8 at 11 mg/kg/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL719883;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring mean tumor diameter on day 8 at 12(mg/kg)/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL722418;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antitumor activity against subcutaneous Colon 38 tumors in mice determined as delay in growth after 3.9 mg/kg/day dose given as 3 times in a day for 4 days;CHEMBL1136718;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL720061;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo growth inhibitory activity was measured against murine P388 leukemia cells as Percent increase in life span at the dose of 2.0 mg/kg/day;CHEMBL1122143;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL719309;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring the percent increase in life span of female DBA2 mice intravenously inoculated with L1210 leukemia at 10 mg/kg/day, iv;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL719310;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring the percent increase in life span of female DBA2 mice intravenously inoculated with L1210 leukemia at 11 mg/kg/day, iv;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL719311;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring the percent increase in life span of female DBA2 mice intravenously inoculated with L1210 leukemia at 12(mg/kg)/day, iv;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL721403;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring the percent increase in life span of female DBA2 mice subcutaneously inoculated with L1210 leukemia at 12(mg/kg)/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL721404;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of female DBA2 mice subcutaneously inoculated with L1210 leukemia at 10 mg/kg/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL716834;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent increase in life span of female DBA2 mice subcutaneously inoculated with L1210 leukemia at 11 mg/kg/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729575;[];Mus musculus;[];;Microsomes;10090.0;;Liver;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage rate of O2 consumption by liver microsomes and NADPH in the presence compared to the rate in presence of doxorubicin.;CHEMBL1122183;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3559723;
CLD0;;;CHEMBL727200;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent median treated tumor size to that of control tumor size in NYH treatment model in mice (in vivo) after intraperitoneal administration of compound (0.5 mg/kg, number of tumors 8);CHEMBL1130292;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL725379;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 10 mg/kg/day, iv; 0/18";CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL725380;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 10 mg/kg/day, sc; 0/58";CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL725381;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 11 mg/kg/day, iv; 0/37";CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL725382;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 11 mg/kg/day, sc; 3/37";CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL725383;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 12(mg/kg)/day, iv; 6/34";CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL725384;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Chemotherapeutic activity was evaluated by measuring number of survivors on day 30 / total number of mice at 12(mg/kg)/day, sc; 3/36";CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL727268;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mice baering P388 leukemia (10e6 cells) implanted ip on day 0, after treatment with three ip doses (8 mg/kg) on day 5,9,13 when tumor became systemic.;CHEMBL1122652;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730201;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 10 mg/kg/day, iv;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730202;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 10 mg/kg/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730203;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 11 mg/kg/day, iv;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730204;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 11 mg/kg/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730205;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 12(mg/kg)/day, iv;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730206;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Chemotherapeutic activity was evaluated by measuring percent change in weight on day 8 at 12(mg/kg)/day, sc;CHEMBL1121551;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;MOLT-4;CHEMBL730942;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against Molt-4 cell line (T-cell leukemia) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614177;;
CLD0;;MOLT-4;CHEMBL730943;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against Molt-4 cell line (T-cell leukemia) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614177;;
CLD0;;;CHEMBL739124;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect of 3 mg/kg/dose of compound given iv q4d x 3 against sc human ovarian tumor (SK-OV3) in mice expressed as Mean tumor volume by day 30;CHEMBL1132380;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P-388;CHEMBL740462;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13th day at 4 mg/kg;CHEMBL1121844;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P-388;CHEMBL740467;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13th day at 8 mg/kg;CHEMBL1121844;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745295;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect of 3 mg/kg/dose of compound given iv q4d x 3 against sc human ovarian tumor (SK-OV3) in mice expressed as treated/ control ( 1000 mm**3) median tumor volume on day 30;CHEMBL1132380;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745296;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect of 3 mg/kg/dose of compound given iv q4d x 3 against sc human ovarian tumor (SK-OV3) in mice expressed as treated/ control mean tumor volume on day 30;CHEMBL1132380;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P-388;CHEMBL748163;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '16.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '16.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13 th day at 16 mg/kg;CHEMBL1121844;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P-388;CHEMBL747430;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for antitumor activity in mice injected intraperitoneal with leukemia P-388 cells, treated on days 5, 9, and 13th day at 2 mg/kg;CHEMBL1121844;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL747434;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;T/C of median tumor volumes when 3 mg/kg/dose of compound was given to BALB/c mice bearing sc M109 on days 1 and 4 (ip) after inoculation (control ~2000 mm**3);CHEMBL1132380;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL747435;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;T/C of median tumor volumes when 3 mg/kg/dose of compound was given to BALB/c mice bearing sc M109 on days 3 and 6 (iv) after inoculation (control ~2000 mm**3);CHEMBL1132380;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL741667;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect of 3 mg/kg/dose of compound given iv q4d x 3 against sc human ovarian tumor (SK-OV3) in mice expressed as % tumor volume change from initial by day 30;CHEMBL1132380;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;NHDF;CHEMBL749391;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307481;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against NHDF cell line (norm human dermal fibroblast) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614200;;
CLD0;;NHDF;CHEMBL746886;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307481;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against NHDF cell line (norm human dermal fibroblast) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614200;;
CLD0;;;CHEMBL748620;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity that caused a 50% reduction in absorbance at 490 nm in normal human fibroblast (NHF) cells using MTS assay.;CHEMBL1133679;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;NCI-H460;CHEMBL748624;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Evaluated in vitro for antiproliferative activity against NIC-H460 cell lines derived from large cell carcinoma of the lung;CHEMBL1130292;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;;CHEMBL749525;[];Equus caballus;[];;;9796.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;Concentration of substrate at which the amount of total cytochrome c reduction is decreased by 10%;CHEMBL1126673;Homologous protein target assigned;H;;1;CHEMBL4499;;
CLD0;;;CHEMBL747977;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;Activity of NADH dehydrogenase was determined;CHEMBL1126673;Homologous protein target assigned;H;;1;CHEMBL4499;;
CLD0;;NSCLC;CHEMBL752559;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307974;Target assigned is non-molecular;1;Evaluated in vitro for antiproliferative activity against NYH cell lines derived from small cell lung cancer;CHEMBL1130292;Non-molecular target assigned;N;;1;CHEMBL612554;;
CLD0;;P388;CHEMBL759008;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated for cytotoxicity against P388 leukemia cell line.;CHEMBL1132380;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;OVCAR-3;CHEMBL754308;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against Ovcar-3 cell line (ovarian carcinoma) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;OVCAR-3;CHEMBL754309;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against Ovcar-3 cell line (ovarian carcinoma) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;P388;CHEMBL758428;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against P-388 cell line (mouse leukemia) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL882419;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against P-388 cell line (mouse leukemia) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756544;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for change in body weight at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756548;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for % increase in life span at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756205;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for median day of death at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758384;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for mortality range at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758537;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for tumor free survivors at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758540;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for total dose at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL761354;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity in mice against leukemia P388 cells at 1.4 uM/kg was expressed as ratio of average survival time;CHEMBL1121745;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756922;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor efficacy at optimal dose of compound was measured against P388 leukemia in mice;CHEMBL1122183;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL760514;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Growth Inhibition of P388/0 cell lines.;CHEMBL1133092;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758655;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated for the antitumor efficacy at optimal dose 8 mg/kg against leukemia P388 in mice on day q4d 5, 9, 13.,;CHEMBL1123251;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL755396;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for change in body weight at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL755397;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for % increase in life span at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758083;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for median day of death at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758084;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for mortality range at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758085;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388 (1303) for tumor free survivors at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758086;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was evaluated in vivo for antitumor activity after intraperitoneal administration against P388/L-PAM for total dose at an optimal dose of 1 mg/kg/injection;CHEMBL1125740;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL758711;[];Sus scrofa;[];;;9823.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;"Inhibition of Pancreatic elastase at 10e-5 M; NI means no inhibition";CHEMBL1126272;Direct protein target assigned;D;;1;CHEMBL2096984;;
CLD0;;L1210;CHEMBL767645;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is molecular non-protein target;3;Inhibition of [3H]uridine incorporation into proliferating L1210 cells.;CHEMBL1122652;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL766426;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for effect of glycoside on superoxide production in rat heart sarcosomes;CHEMBL1123433;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL773701;[];Rattus norvegicus;[];;Microsomal;10116.0;;Liver;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for augmentation of rat liver microsomal oxygen consumption relative to doxorubicin;CHEMBL1121844;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3559723;
CLD0;;SK-MEL-28;CHEMBL804094;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against SK-Mel-28 cell line (melanoma) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614919;;
CLD0;;SK-MEL-28;CHEMBL804095;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against SK-Mel-28 cell line (melanoma) after incubation for 72 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL614919;;
CLD0;;;CHEMBL802171;[];Clupeidae;[];;;55118.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Apparent binding affinity to herring sperm DNA at 25 degree Celsius in PBS buffer with pH 7.4;CHEMBL1121550;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL802172;[];Clupeidae;[];;;55118.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Maximal binding (nmax) sites to herring sperm DNA. Estimated from Scatchard plots;CHEMBL1121550;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL810265;[];Staphylococcus aureus;[];;;1280.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for antibacterial activity against Staphylococcus aureus ATCC 25923;CHEMBL1123433;Non-molecular target assigned;N;;1;CHEMBL352;;
CLD0;;;CHEMBL810266;[];Staphylococcus aureus;[];;;1280.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for antibacterial activity against Staphylococcus aureus ATCC 9144;CHEMBL1123433;Non-molecular target assigned;N;;1;CHEMBL352;;
CLD0;;;CHEMBL809626;[];Staphylococcus aureus;[];;;1280.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for antibacterial activity against Staphylococcus aureus WSU-196E;CHEMBL1123433;Non-molecular target assigned;N;;1;CHEMBL352;;
CLD0;;;CHEMBL811543;[];staphylococcus epidermitis;[];;;1282.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for antibacterial activity against Staph. epidermidis ATCC 12228;CHEMBL1123433;Non-molecular target assigned;N;;1;CHEMBL353;;
CLD0;;;CHEMBL810787;[];Streptococcus pyogenes;[];;;1314.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for antibacterial activity against Strep. pyogenes ATCC 19615;CHEMBL1123433;Non-molecular target assigned;N;;1;CHEMBL356;;
CLD0;;T-24;CHEMBL871855;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307700;Target assigned is non-molecular;1;Antiproliferative activity of compound was tested against bladder carcinoma (T-24) human tumor cells;CHEMBL1128100;Non-molecular target assigned;N;;1;CHEMBL614774;;
CLD0;;;CHEMBL821429;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Binding constant was measured against inhibition of DNA relaxation by topoisomerase I at 20 uM concentration;CHEMBL1127472;Homologous protein target assigned;H;;1;CHEMBL1781;;
CLD0;;;CHEMBL821436;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;"Ratio of DNA relaxation times by topoisomerase in presence of 20 uM of compound (t1/e(+drug) / t 1/e(-drug)); Complete inhibition";CHEMBL1127472;Homologous protein target assigned;H;;1;CHEMBL1781;;
CLD0;;;CHEMBL814845;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;Ratio of DNA relaxation times by topoisomerase in presence of 2 uM of compound (t1/e(+drug) / t 1/e(-drug));CHEMBL1127472;Homologous protein target assigned;H;;1;CHEMBL1781;;
CLD0;;;CHEMBL811762;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Lethal dose of compound required when administered BALB C mice;CHEMBL1126488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL808433;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibitory activity against telomerase at 50 uM concentration (Compound released from DNA/DNA heteroduplex derivatized resin [sequence (TTAGGG)3);CHEMBL1133811;Homologous protein target assigned;H;;1;CHEMBL2916;;
CLD0;;;CHEMBL808654;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibitory activity against telomerase at 50 uM concentration (Compound released from RNA/DNA heteroduplex derivatized resin [sequence (TTAGGG)3);CHEMBL1133811;Homologous protein target assigned;H;;1;CHEMBL2916;;
CLD0;;;CHEMBL808655;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibitory activity against telomerase at 50 uM concentration (Compound released from underivatized resin;CHEMBL1133811;Homologous protein target assigned;H;;1;CHEMBL2916;;
CLD0;;;CHEMBL813733;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;"Inhibitory activity against trypsin at 10e-5 M; NI = no inhibition";CHEMBL1126272;Homologous protein target assigned;H;;1;CHEMBL209;;
CLD0;;UCLA P-3;CHEMBL816276;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307243;Target assigned is non-molecular;1;Cytotoxicity of compound was tested against UCLA P-3 cell line (lung carcinoma) after incubation for 24 hour;CHEMBL1126488;Non-molecular target assigned;N;;1;CHEMBL612797;;
CLD0;;WiDr;CHEMBL815821;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Cytotoxicity against WIDR tumor cell line;CHEMBL1132544;Non-molecular target assigned;N;;1;CHEMBL614647;;
CLD0;;WALKER;CHEMBL819955;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307478;Target assigned is non-molecular;1;In vitro antiproliferative activity against Walker cell line;CHEMBL1130292;Non-molecular target assigned;N;;1;CHEMBL613532;;
CLD0;;WiDr;CHEMBL819655;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Antiproliferative activity of compound was tested against colon carcinoma (WiDr) human tumor cells;CHEMBL1128100;Non-molecular target assigned;N;;1;CHEMBL614647;;
CLD0;;YOSHIDA;CHEMBL821051;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308014;Target assigned is non-molecular;1;In vitro antiproliferative activity against Yoshida cell lines;CHEMBL1130292;Non-molecular target assigned;N;;1;CHEMBL612816;;
CLD0;;YOSHIDA;CHEMBL821052;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308014;Target assigned is non-molecular;1;Concentration inhibiting [3H]TdR incorporation in Yoshida sarcoma tumor cells in vitro in rats;CHEMBL1126272;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL824120;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Thermal denaturation for stabilization of helical DNA by the compound;CHEMBL1121844;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;P388;CHEMBL841827;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against P-388 leukemia cell line in BDF1 mice after injecting 8.0 mg/kg ip dose;CHEMBL1124896;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL845198;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibitory concentration in presence of MDR inhibitor XR-9576;CHEMBL1146678;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;MDR;CHEMBL845906;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308422;Default value - Target unknown or has yet to be assigned;0;Resistant Factor against MDR cell lines. Value expressed as ratio of IC50 on the resistant cell and on the corresponding sensitive cells.;CHEMBL1129201;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL844595;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;"Ratio of the extracellular cytotoxicities against MDA MB 361(mammary carcinoma cell line) expressing LacZ and carboxypeptidase stCPG2 of the prodrug.; Not available";CHEMBL1132269;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL844606;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;"Ratio of the intracellular cytotoxicities against MDA MB 361(mammary carcinoma cell line) expressing LacZ (beta-galactosidase). between prodrug and drug.; Not available";CHEMBL1132269;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL852131;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Relative resistance value of Adriamycin resistant L-1210/L-1210 parental cell line;CHEMBL1128855;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL850179;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;NADH oxidation by the compound was determined;CHEMBL1126673;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;K562;CHEMBL825138;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against K562 leukemia cell line done for 72 hr at 37 degree C with compound in MTS assay;CHEMBL1145165;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;SW-620;CHEMBL833954;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307944;Target assigned is non-molecular;1;Cytotoxicity against SW620 colon cancer cell line done for 72 h at 37 degree C with compound in MTS assay;CHEMBL1145165;Non-molecular target assigned;N;;1;CHEMBL612262;;
CLD0;;Jurkat;CHEMBL861462;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Target assigned is non-molecular;1;Cytotoxicity against Jurkat T lymphocytes by MTT assay;CHEMBL1140422;Non-molecular target assigned;N;;1;CHEMBL397;;
CLD0;;K562;CHEMBL865222;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Increase in the level of drug uptake in Dox-resistant K562 cells in presence of cyclosporine over its absence;CHEMBL1149383;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL865223;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Increase in the level of drug efflux in Dox-resistant K562 cells in presence of cyclosporine over its absence;CHEMBL1149383;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL865225;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against K562 cells by MTS;CHEMBL1149383;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL865226;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against Dox-resistant K562 cells by MTS;CHEMBL1149383;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL865897;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Drug resistance index, ratio of IC50 in Dox-resistant K562 cells over Dox-sensitive cells;CHEMBL1149383;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL867073;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against Dox-resistant K562 cells by MTS at 1 uM and in presence of cyclosporine;CHEMBL1149383;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL867075;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against Dox-resistant K562 cells by MTS at 1 uM and in absence of cyclosporine;CHEMBL1149383;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;;CHEMBL865857;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Mortality in mice with Dox-resistant K562 xenografts in 20 days at 5-10 mg/kg, ip;CHEMBL1149383;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;K562;CHEMBL860573;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against drug-sensitive K562 cell line by MTS assay;CHEMBL1138154;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL861415;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against doxorubicin-resistant K562 cell line by MTS assay;CHEMBL1138154;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL860243;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Drug resistance index (ratio of IC50 in drug-resistant cells over drug-sensitive cells);CHEMBL1138154;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;HeLa;CHEMBL871091;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa3 cell line by MTT assay;CHEMBL1146888;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;MDA-MB-435;CHEMBL855605;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against multidrug resistant MDA435/LCC6 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;MDA-MB-435;CHEMBL855609;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against MDA435/LCC6 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;P388/ADR;CHEMBL855610;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;Antiproliferative activity against adriamycin resistant P388 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614218;;
CLD0;;P388;CHEMBL855617;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against P388 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;MDA-MB-435;CHEMBL855045;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;MDA-MB-435;CHEMBL855046;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM verapamil by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;MDA-MB-435;CHEMBL855052;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant MDA435/LCC6 cells;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;P388/ADR;CHEMBL855054;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614218;;
CLD0;;P388/ADR;CHEMBL855055;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM verapamil by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614218;;
CLD0;;P388;CHEMBL855056;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant P388 cells;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL855057;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Relative fold, IC50 in absence to presence of verapamil in multidrug resistant P388 cells;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;MES-SA ;CHEMBL914270;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;Antiproliferative activity against drug sensitive Messa cell line by Alamar Blue assay;CHEMBL1142860;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MES-SA/Dx5;CHEMBL914271;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308373;Target assigned is non-molecular;1;Antiproliferative activity against drug resistant Messa/DX5 cell line expressing MDR1 by Alamar Blue assay;CHEMBL1142860;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HCT-15;CHEMBL913184;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307945;Target assigned is non-molecular;1;Antiproliferative activity against drug resistant HCT15 cell line expressing MDR1 by Alamar Blue assay;CHEMBL1142860;Non-molecular target assigned;N;;1;CHEMBL612263;;
CLD0;;ACHN;CHEMBL913185;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307633;Target assigned is non-molecular;1;Antiproliferative activity against drug resistant ACHN cell line expressing MDR1 by Alamar Blue assay;CHEMBL1142860;Non-molecular target assigned;N;;1;CHEMBL614519;;
CLD0;;NCI-H69;CHEMBL913186;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307712;Target assigned is non-molecular;1;Antiproliferative activity against drug sensitive NCI-H69 cell line by Alamar Blue assay;CHEMBL1142860;Non-molecular target assigned;N;;1;CHEMBL614805;;
CLD0;;H69AR;CHEMBL913187;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL5209887;Target assigned is non-molecular;1;Antiproliferative activity against drug resistant H69AR cell line expressing MRP1 by Alamar Blue assay;CHEMBL1142860;Non-molecular target assigned;N;;1;CHEMBL5209893;;
CLD0;;CCRF-CEM;CHEMBL890790;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against CEM cells after 72 hrs;CHEMBL1146230;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;MCF7;CHEMBL890791;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against MCF7 cells after 72 hrs;CHEMBL1146230;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;K562;CHEMBL890792;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against K562 cells after 72 hrs;CHEMBL1146230;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;ARN8;CHEMBL890793;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against ARN8 cells after 72 hrs;CHEMBL1146230;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;G-361;CHEMBL890794;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307514;Target assigned is non-molecular;1;Cytotoxicity against human G361 cells after 72 hrs;CHEMBL1146230;Non-molecular target assigned;N;;1;CHEMBL614036;;
CLD0;;HeLa;CHEMBL890795;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against HeLa cells after 72 hrs;CHEMBL1146230;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HOS;CHEMBL890796;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308811;Target assigned is non-molecular;1;Cytotoxicity against HOS cells after 72 hrs;CHEMBL1146230;Non-molecular target assigned;N;;1;CHEMBL614736;;
CLD0;;A549;CHEMBL890797;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against A549 cells after 72 hrs;CHEMBL1146230;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;NIH3T3;CHEMBL890798;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against mouse NIH 3T3 cells after 72 hrs;CHEMBL1146230;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL886158;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Displacement of methyl green from DNA;CHEMBL1139930;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;A2780 ADR;CHEMBL925477;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3988401;Target assigned is non-molecular;1;Cytotoxicity against human A2780/ADR cells after 72 hrs by MTT assay;CHEMBL1140531;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;A2780;CHEMBL925478;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Cytotoxicity against human A2780 cells after 72 hrs by MTT assay;CHEMBL1140531;Non-molecular target assigned;N;;1;CHEMBL614004;;
CLD0;;;CHEMBL936123;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of synthetic amyloid beta-42 oligomerization by ELISA;CHEMBL1143831;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL936122;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of synthetic amyloid beta42 oligomer formation by Western blot;CHEMBL1143831;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL936124;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of synthetic amyloid beta-42 fibrillation by ThT fluorescence analysis relative to control;CHEMBL1143831;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL936125;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of synthetic amyloid beta-42 fibrillation by light scattering analysis relative to control;CHEMBL1143831;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;NS1;CHEMBL1008687;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against mouse NS1 cells after 72 hrs by microtiter plate assay;CHEMBL1148926;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1008688;[];Bacillus subtilis;[];;;1423.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by microtiter plate assay;CHEMBL1148926;Non-molecular target assigned;N;;1;CHEMBL359;;
CLD0;;;CHEMBL968662;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Displacement of methyl green from DNA after 24 hrs by microtiter assay;CHEMBL1150052;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL968663;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Displacement of ethidium bromide from calf thymus type 1 DNA after 24 hrs by microtiter assay;CHEMBL1150052;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;NIH3T3;CHEMBL939585;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307716;Target assigned is non-molecular;1;Intrinsic cytotoxicity against mouse NIH/3T3 cells overexpressing MDR1 after 72 hrs by MTT assay;CHEMBL1152290;Non-molecular target assigned;N;;1;CHEMBL614822;;
CLD0;;NIH3T3;CHEMBL939586;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;Intrinsic cytotoxicity against wild type mouse NIH/3T3 cells after 72 hrs by MTT assay;CHEMBL1152290;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;NIH3T3;CHEMBL939587;[];Mus musculus;[];;;10090.0;;;U;Unassigned;BAO_0000219;cell-based format;CHEMBL3307716;Target assigned is non-molecular;1;Resistance index, ratio of IC50 for mouse NIH/3T3 cells expressing MDR1 to IC50 for wild type mouse NIH/3T3 cells;CHEMBL1152290;Non-molecular target assigned;N;;1;CHEMBL614822;;
CLD0;;C6;CHEMBL987562;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Cytotoxicity against rat C6 cells at 50 ug/mL to 2.5 mg/mL after 3 days treated 4 hrs before db-cAMP challenge by MTT assay;CHEMBL1158219;Non-molecular target assigned;N;;1;CHEMBL614657;;
CLD0;;C6;CHEMBL987566;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308345;Default value - Target unknown or has yet to be assigned;0;Inhibition of tubulin polymerization in rat C6 cells at 50 ug/mL to 2.5 mg/mL after 4 hrs;CHEMBL1158219;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;C6;CHEMBL988383;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Cytotoxicity against rat C6 cells assessed as cell release at 50 ug/mL to 2.5 mg/mL after 5 hrs by MTT assay in absence of db-cAMP;CHEMBL1158219;Non-molecular target assigned;N;;1;CHEMBL614657;;
CLD0;;;CHEMBL991974;[];Human immunodeficiency virus 1;[];;;11676.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli;CHEMBL1158321;Direct protein target assigned;D;;1;CHEMBL247;;
CLD0;;HT-29;CHEMBL981345;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981347;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981348;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981349;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;P388;CHEMBL981350;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981351;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981352;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981353;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL947536;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as reduction in DNA peak by pre-incubation method;CHEMBL1150198;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL947537;[];Saccharomyces cerevisiae;[];;;4932.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to yeast tRNA assessed as reduction in tRNA peak by pre-incubation method;CHEMBL1150198;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;HT-29;CHEMBL1009001;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay;CHEMBL1150119;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HCT-116;CHEMBL1009002;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay;CHEMBL1150119;Non-molecular target assigned;N;;1;CHEMBL394;;
CLD0;;HRT-18 cell line;CHEMBL1009003;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308672;Target assigned is non-molecular;1;Cytotoxicity against human HRT18 cells after 48 hrs by MTT assay;CHEMBL1150119;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MCF7;CHEMBL1009004;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells expressing estrogen receptor after 48 hrs by MTT assay;CHEMBL1150119;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;LNCaP;CHEMBL1009005;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307965;Target assigned is non-molecular;1;Cytotoxicity against human LNCAP cells expressing androgen receptor after 48 hrs by MTT assay;CHEMBL1150119;Non-molecular target assigned;N;;1;CHEMBL612518;;
CLD0;;PC-3;CHEMBL1009006;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells after 48 hrs by MTT assay;CHEMBL1150119;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;KB ;CHEMBL1006410;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Induction of apoptotic activity in human KB cells at 1 uM after 24 hrs;CHEMBL1156629;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;MCF7;CHEMBL975110;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay;CHEMBL1158125;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MDA-MB-231;CHEMBL975111;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay;CHEMBL1158125;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;PC-3;CHEMBL975112;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC-3 cells after 48 hrs by MTT assay;CHEMBL1158125;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;HeLa;CHEMBL975113;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells after 48 hrs by MTT assay;CHEMBL1158125;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;;CHEMBL989024;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA in BPES buffer assessed as binding constant K/10'5 by fluorescence titration;CHEMBL1140110;Molecular target other than protein assigned;M;;1;CHEMBL3140325;;
CLD0;;HL-60;CHEMBL1017687;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 48 hrs by trypan blue exclusion method;CHEMBL1154463;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL1017692;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Induction of apoptosis in multidrug resistant human HL60 cells after 48 hrs;CHEMBL1154463;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;;CHEMBL1018093;[];Human immunodeficiency virus 1;[];;;11676.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of HIV1 RT;CHEMBL1137798;Direct protein target assigned;D;;1;CHEMBL247;;
CLD0;;HeLa;CHEMBL1030895;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as inhibition of colony formation at 25 ng/ml relative to control;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HeLa;CHEMBL1030896;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as colony formation at 12.5 ng/ml relative to control;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HeLa;CHEMBL1030897;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as colony formation at 6.2 ng/ml relative to control;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HeLa;CHEMBL1030900;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as inhibition of colony formation relative to control;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;P388;CHEMBL1030901;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Cytotoxicity against mouse P388 cells;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL1030902;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Cytotoxicity against doxorubicin resistant mouse P388 cells;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL1030903;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.9', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.9'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells xenografted in mouse assessed as median survival time at 2.9 mg/kg, ip relative to control;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL1030904;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.4', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.4'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells xenografted in mouse assessed as median survival time at 4.4 mg/kg, ip relative to control;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL1030905;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '6.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.6'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells xenografted in mouse assessed as median survival time at 6.6 mg/kg, ip relative to control;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL1030910;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.9', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.9'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells xenografted mouse assessed as induction of death at 2.9 mg/kg, ip;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL1030911;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.4', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.4'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells xenografted mouse assessed as induction of death at 4.4 mg/kg, ip;CHEMBL1151653;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL965578;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOA;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3681;;
CLD0;;;CHEMBL965580;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOB;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3050;;
CLD0;;;CHEMBL1046150;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Permeability at pH 6.5 by PAMPA method;CHEMBL1156784;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1046151;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Oral bioavailability in human;CHEMBL1156784;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;NCI60;CHEMBL1070375;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Growth inhibition of human NCI60 cells;CHEMBL1157691;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;KB ;CHEMBL1100804;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 48 hrs by MTT assay;CHEMBL1153791;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB-C2;CHEMBL1100805;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human multidrug resistant KB-C2 cells after 48 hrs by MTT assay;CHEMBL1153791;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MCF7;CHEMBL1100807;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay;CHEMBL1153791;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;K562;CHEMBL1100808;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells after 48 hrs by MTT assay;CHEMBL1153791;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL1100809;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human doxorubicin-resistant K562 cells after 48 hrs by MTT assay;CHEMBL1153791;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;COLO 205;CHEMBL1100810;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;Cytotoxicity against human COLO205 cells after 48 hrs by MTT assay;CHEMBL1153791;Non-molecular target assigned;N;;1;CHEMBL614561;;
CLD0;;MDA-MB-231;CHEMBL1105085;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cytotoxicity against human MDA-MB-231 cells after 72 hrs by sulforhodamine B assay;CHEMBL1154817;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;A549;CHEMBL1105916;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells after 72 hrs by sulforhodamine B assay;CHEMBL1154817;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;HT-29;CHEMBL1105917;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT-29 cells after 72 hrs by sulforhodamine B assay;CHEMBL1154817;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HEK293;CHEMBL1105860;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Cytotoxicity against HEK293 cells at 400 nM after 48 hrs by resazurin conversion-based fluorometric assay;CHEMBL1154261;Non-molecular target assigned;N;;1;CHEMBL614818;;
CLD0;;KB ;CHEMBL1112634;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 48 hrs by MTT assay;CHEMBL1156240;Non-molecular target assigned;N;;1;CHEMBL398;;
CLD0;;KB-C2;CHEMBL1112635;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human multidrug-resistant KB-C2 cells after 48 hrs by MTT assay;CHEMBL1156240;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1108963;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Octanol-water partition coefficient, log P of the compound;CHEMBL1157036;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;MCF7;CHEMBL1176773;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells at 4 ug/ml after 48 hrs by sulforhodamine B assay relative to control;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;NCI-H460;CHEMBL1176774;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H460 cells at 4 ug/ml after 48 hrs by sulforhodamine B assay relative to control;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;SF-268;CHEMBL1176775;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Cytotoxicity against human SF268 cells at 4 ug/ml after 48 hrs by sulforhodamine B assay relative to control;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL613977;;
CLD0;;MCF7;CHEMBL1176776;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 72 hrs by XTT assay;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;NCI-H460;CHEMBL1176777;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H460 cells after 72 hrs by XTT assay;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;SF-268;CHEMBL1176778;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Cytotoxicity against human SF268 cells after 72 hrs by XTT assay;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL613977;;
CLD0;;Detroit 551;CHEMBL1176779;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307358;Target assigned is non-molecular;1;Cytotoxicity against human Detroit 551 cells after 72 hrs by XTT assay;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL614284;;
CLD0;;MCF7;CHEMBL1176780;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Selectivity index, ratio of GI50 for human Detroit 551 cells to GI50 for human MCF7 cells;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;NCI-H460;CHEMBL1176781;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Selectivity index, ratio of GI50 for human Detroit 551 cells to GI50 for human NCI-H460 cells;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;SF-268;CHEMBL1176782;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Selectivity index, ratio of GI50 for human Detroit 551 cells to GI50 for human SF268 cells;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL613977;;
CLD0;;K562;CHEMBL1176783;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells after 72 hrs by XTT assay;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL1176784;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Selectivity index, ratio of GI50 for human Detroit 551 cells to GI50 for human K562 cells;CHEMBL1177675;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;;CHEMBL1250112;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to human c-MYC Pu24I G-quadruplex structure assessed as stabilization of G-quadruplex by NMR spectroscopy;CHEMBL1240302;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL1250925;[];Gallus gallus;[];;;9031.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to histone H1 containing chromatin in chicken erythroleukemic cells mononucleosomes transformed with Marek's virus by Scatchard plot analysis;CHEMBL1250493;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1250926;[];Gallus gallus;[];;;9031.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to histone H1 depleted chromatin in chicken erythroleukemic cells mononucleosomes transformed with Marek's virus by Scatchard plot analysis;CHEMBL1250493;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1286008;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as change in melting temperature at drug/DNA ratio 1;CHEMBL1275381;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL1286011;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Displacement of DNA-bound ethidium bromide from calf thymus DNA by fluorescence assay;CHEMBL1275381;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL1285392;[];Candida albicans;[];;;5476.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u;CHEMBL1275276;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1285393;[];Saccharomyces cerevisiae;[];AD1-8u;;4932.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay;CHEMBL1275276;Non-molecular target assigned;N;;1;CHEMBL361;;
CLD0;;;CHEMBL1285394;[];Candida albicans;[];;;5476.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u;CHEMBL1275276;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1285395;[];Saccharomyces cerevisiae;[];AD1-8u;;4932.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay;CHEMBL1275276;Non-molecular target assigned;N;;1;CHEMBL361;;
CLD0;confirmatory;;CHEMBL1614117;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;"PUBCHEM_BIOASSAY: qHTS Confirmation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 2528 (qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";CHEMBL1201862;Direct protein target assigned;D;2585;7;CHEMBL1293237;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614132;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-021. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;974;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614166;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;2675;7;CHEMBL1293317;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614168;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP1-002 - Assay at 24 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;993;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614174;[];Bacillus subtilis;[];;;1423.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1490;7;CHEMBL1293248;;
CLD0;confirmatory;;CHEMBL1614234;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ];CHEMBL1201862;Direct protein target assigned;D;1457;7;CHEMBL1293238;;
CLD0;confirmatory;;CHEMBL1614236;[];Influenza A virus (A/WSN/1933(H1N1));[];;;382835.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2326;7;CHEMBL1293303;;
CLD0;confirmatory;;CHEMBL1614249;[];Equus caballus;[];;;9796.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)];CHEMBL1201862;Direct protein target assigned;D;485281;7;CHEMBL1293254;;
CLD0;confirmatory;;CHEMBL1614250;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ];CHEMBL1201862;Direct protein target assigned;D;1468;7;CHEMBL1293224;;
CLD0;confirmatory;;CHEMBL1614303;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore). (Class of assay: confirmatory) [Related pubchem assays: 875 ];CHEMBL1201862;Direct protein target assigned;D;892;7;CHEMBL5990;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614393;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-012. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;982;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614456;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 915 ];CHEMBL1201862;Direct protein target assigned;D;914;7;CHEMBL4261;;
CLD0;confirmatory;;CHEMBL1614458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))];CHEMBL1201862;Direct protein target assigned;D;1030;7;CHEMBL3577;;
CLD0;confirmatory;;CHEMBL1614459;[];Drosophila;[];;;7215.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;2685;7;CHEMBL612545;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614518;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-025. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;976;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614521;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]";CHEMBL1201862;Direct protein target assigned;D;1454;7;CHEMBL4040;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614528;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-018. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;985;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613785;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-010. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;981;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1613797;[];Bacillus anthracis str. A2012;[];;;191218.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;912;7;CHEMBL4372;;
CLD0;confirmatory;;CHEMBL1613803;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 914 ];CHEMBL1201862;Direct protein target assigned;D;915;7;CHEMBL4261;;
CLD0;confirmatory;;CHEMBL1613808;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;995;7;CHEMBL4040;;
CLD0;confirmatory;;CHEMBL1614257;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1768;7;CHEMBL2093861;;
CLD0;confirmatory;;CHEMBL1614267;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;961;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614275;[];Giardia intestinalis;[];;;5741.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ];CHEMBL1201862;Direct protein target assigned;D;2451;7;CHEMBL1293234;;
CLD0;confirmatory;;CHEMBL1614281;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;938;7;CHEMBL1963;;
CLD0;confirmatory;;CHEMBL1614328;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;"PUBCHEM_BIOASSAY: Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay. (Class of assay: confirmatory) [Related pubchem assays: 2528 (qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2585 (qHTS Confirmation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";CHEMBL1201862;Default value - Target has yet to be curated;U;2712;7;CHEMBL612545;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614329;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP1-003 - Assay at 40 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;964;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614342;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485313;7;CHEMBL1293277;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614349;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;946;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614399;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response. (Class of assay: confirmatory) [Related pubchem assays: 914 (Primary screen.), 915 (Primary screen.)];CHEMBL1201862;Direct protein target assigned;D;2120;7;CHEMBL4261;;
CLD0;confirmatory;;CHEMBL1614410;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)];CHEMBL1201862;Direct protein target assigned;D;2662;7;CHEMBL1293299;;
CLD0;confirmatory;;CHEMBL1614466;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) [Related pubchem assays: 1705 (qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) ), 2324 (Probe Development Summary of Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1707 (Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay), 2517 (qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1708 (Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV)];CHEMBL1201862;Direct protein target assigned;D;2572;7;CHEMBL5619;;
CLD0;confirmatory;;CHEMBL1614474;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter. (Class of assay: confirmatory) [Related pubchem assays: 2281 (Summary of qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a), 463106 (LOPAC Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a)];CHEMBL1201862;Direct protein target assigned;D;463254;7;CHEMBL1293227;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614477;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-011. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;969;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614531;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1766;7;CHEMBL2093861;;
CLD0;confirmatory;;CHEMBL1614554;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1469;7;CHEMBL1947;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613813;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-022. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;987;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1613829;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))];CHEMBL1201862;Direct protein target assigned;D;2549;7;CHEMBL1293236;;
CLD0;confirmatory;;CHEMBL1613874;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: Tumor Hsp90 Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 429 (Primary screen preceding this dose response confirmation assay.)];CHEMBL1201862;Direct protein target assigned;D;712;7;CHEMBL2095165;;
CLD0;confirmatory;;CHEMBL1613897;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay. (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2549 (qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))];CHEMBL1201862;Default value - Target has yet to be curated;U;2711;7;CHEMBL612545;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613904;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-026. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;989;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1613910;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;893;7;CHEMBL4159;;
CLD0;confirmatory;;CHEMBL1613914;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2147;7;CHEMBL1293226;;
CLD0;confirmatory;;CHEMBL1613918;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ];CHEMBL1201862;Direct protein target assigned;D;1688;7;CHEMBL5514;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613947;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-009. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;968;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1613948;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: Cell-based secondary assay for identifying Hsp90 inhibitors that degrade Hsp90 client protein Her2. (Class of assay: confirmatory) [Related pubchem assays: 429 (Primary screen preceding this dose response confirmation assay.)];CHEMBL1201862;Direct protein target assigned;D;754;7;CHEMBL2095165;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613950;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-015. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;971;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613964;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;955;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613967;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-020. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;986;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1613970;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay for Compounds that Induce Erasure of Genomic Imprints. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1948;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613992;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;902;7;CHEMBL4096;;
CLD0;confirmatory;;CHEMBL1613995;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ];CHEMBL1201862;Direct protein target assigned;D;924;7;CHEMBL4096;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614008;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP1-002 - Assay at 40 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;994;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614049;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-007. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;979;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614052;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1461;7;CHEMBL5162;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614053;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-013. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;970;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614067;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";CHEMBL1201862;Direct protein target assigned;D;2528;7;CHEMBL1293237;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614072;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-014. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;983;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614079;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485314;7;CHEMBL2392;;
CLD0;confirmatory;;CHEMBL1614087;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2551;7;CHEMBL1293231;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614092;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-019. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;973;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614097;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-024. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;988;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614108;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ];CHEMBL1201862;Direct protein target assigned;D;885;7;CHEMBL340;;
CLD0;confirmatory;;CHEMBL1614146;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21. (Class of assay: confirmatory) ;CHEMBL1201862;Molecular target other than protein assigned;M;2289;7;CHEMBL1615322;;
CLD0;confirmatory;;CHEMBL1614211;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;2517;7;CHEMBL5619;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614215;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-004. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;966;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614216;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-001. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;921;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614218;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;960;7;CHEMBL612545;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614231;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-002. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;977;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614356;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-017. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;972;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614361;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;926;7;CHEMBL1963;;
CLD0;confirmatory;;CHEMBL1614364;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485290;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL1614421;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ];CHEMBL1201862;Direct protein target assigned;D;1460;7;CHEMBL1293224;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614425;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;947;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614427;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: 14-3-3 protein interaction modulators Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 422 (Primary screen preceding this dose response confirmation assay.)];CHEMBL1201862;Direct protein target assigned;D;711;7;CHEMBL1293296;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614435;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;962;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614441;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2546;7;CHEMBL1293231;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614486;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-023. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;975;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614492;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-008. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;980;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1613776;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1479;7;CHEMBL1947;;
CLD0;confirmatory;;CHEMBL1613836;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Activators of miR-21. (Class of assay: confirmatory) ;CHEMBL1201862;Molecular target other than protein assigned;M;2288;7;CHEMBL1615322;;
CLD0;confirmatory;;CHEMBL1613838;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485297;7;CHEMBL1293294;;
CLD0;confirmatory;;CHEMBL1613842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1458;7;CHEMBL1293232;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613853;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-016. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;984;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613876;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-005. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;967;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1613886;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ];CHEMBL1201862;Direct protein target assigned;D;884;7;CHEMBL340;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613890;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-003. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;965;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613919;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP1-002 - Assay at 16 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;948;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613942;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-006. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;978;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614036;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP1-003 - Assay at 24 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;963;7;CHEMBL614696;;
CLD0;;MCF7;CHEMBL1647771;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as cell viability at 25 uM after 24 hrs by MTS assay;CHEMBL1641417;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL1647772;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as cell viability at 20 uM after 24 hrs by MTS assay;CHEMBL1641417;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;HT-29;CHEMBL1647773;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT-29 cells assessed as cell viability at 25 uM after 24 hrs by MTS assay;CHEMBL1641417;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL1647774;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT-29 cells assessed as cell viability at 20 uM after 24 hrs by MTS assay;CHEMBL1641417;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HepG2;CHEMBL1647775;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells assessed as cell viability at 25 uM after 24 hrs by MTS assay;CHEMBL1641417;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;HepG2;CHEMBL1647776;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells assessed as cell viability at 16 uM after 24 hrs by MTS assay;CHEMBL1641417;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;MCF7;CHEMBL1647777;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 24 hrs by MTS assay;CHEMBL1641417;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;HT-29;CHEMBL1647778;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT-29 cells after 24 hrs by MTS assay;CHEMBL1641417;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HepG2;CHEMBL1647779;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells after 24 hrs by MTS assay;CHEMBL1641417;Non-molecular target assigned;N;;1;CHEMBL395;;
CLD0;;;CHEMBL1647783;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human CRL7761 cells after 3 days by MTS assay;CHEMBL1641417;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;Vero;CHEMBL1647784;[];Chlorocebus sabaeus;[];;;60711.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307520;Target assigned is non-molecular;1;Cytotoxicity against african green monkey Vero cells after 3 days by MTS assay;CHEMBL1641417;Non-molecular target assigned;N;;1;CHEMBL391;;
CLD0;;NIH3T3;CHEMBL1647785;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against mouse NIH/3T3 cells after 3 days by MTS assay;CHEMBL1641417;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1647793;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human recombinant DNA topoisomerase 1-mediated DNA cleavage assessed as decrease in relaxation of supercoiled plasmid substrate DNA at 5 uM after 30 mins by agarose gel electrophoresis;CHEMBL1641417;Direct protein target assigned;D;;1;CHEMBL1781;;
CLD0;;;CHEMBL1647795;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human recombinant DNA topoisomerase 2alpha-mediated DNA cleavage assessed as decrease in relaxation of supercoiled plasmid substrate DNA at 20 uM after 30 mins by agarose gel electrophoresis;CHEMBL1641417;Direct protein target assigned;D;;1;CHEMBL1806;;
CLD0;;MCF7;CHEMBL1646855;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay;CHEMBL1641525;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;;CHEMBL1692847;[];Leishmania major;[];;;5664.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Resistant index, ratio of EC50 for tafenoquine-resistant promastigotes of Leishmania major R4 to EC50 for promastigotes of Leishmania major MHOM/JL/80/Friedlin;CHEMBL1687853;Non-molecular target assigned;N;;1;CHEMBL612879;;
CLD0;;;CHEMBL1692848;[];Leishmania major;[];R4;;5664.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileishmanial activity against tafenoquine-resistant promastigotes of Leishmania major R4 assessed as inhibition of parasite growth after 72 hrs by MTT assay;CHEMBL1687853;Non-molecular target assigned;N;;1;CHEMBL612879;;
CLD0;;;CHEMBL1692849;[];Leishmania major;[];MHOM/JL/80/Friedlin;;5664.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileishmanial activity against wild type promastigotes of Leishmania major MHOM/JL/80/Friedlin assessed as inhibition of parasite growth after 72 hrs by MTT assay;CHEMBL1687853;Non-molecular target assigned;N;;1;CHEMBL612879;;
CLD0;;;CHEMBL1697778;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697779;[];Rodentia;[];;;9989.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697780;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697797;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA HLAED, liver enzyme composite activity;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697798;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, alkaline phosphatase increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697799;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697800;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697801;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, lactate dehydrogenase (LDH) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697802;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, gamma-glutamyl transferase (GGT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;confirmatory;;CHEMBL1738312;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391];CHEMBL1201862;Direct protein target assigned;D;504333;7;CHEMBL1741220;;
CLD0;confirmatory;;CHEMBL1613800;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702];CHEMBL1201862;Direct protein target assigned;D;881;7;CHEMBL2457;;
CLD0;confirmatory;;CHEMBL1738588;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125];CHEMBL1201862;Direct protein target assigned;D;504467;7;CHEMBL1741209;;
CLD0;confirmatory;;CHEMBL1613933;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375];CHEMBL1201862;Direct protein target assigned;D;1477;7;CHEMBL2093862;;
CLD0;confirmatory;;CHEMBL1737902;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355];CHEMBL1201862;Default value - Target has yet to be curated;U;493014;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1737904;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PubChem BioAssay. qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;504375;7;CHEMBL2093862;;
CLD0;confirmatory;HeLa;CHEMBL1737978;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: 24 hour HeLa Cytotox assay Measured in Cell-Based System Using Plate Reader - 2117-03_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431];CHEMBL1201862;Non-molecular target assigned;N;504726;7;CHEMBL399;;
CLD0;confirmatory;;CHEMBL1737991;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402];CHEMBL1201862;Direct protein target assigned;D;504339;7;CHEMBL5896;;
CLD0;confirmatory;;CHEMBL1737994;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444];CHEMBL1201862;Default value - Target has yet to be curated;U;504648;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738184;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648];CHEMBL1201862;Direct protein target assigned;D;504444;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL1738186;[];Salmonidae;[];;;8015.0;;;B;Binding;BAO_0000217;biochemical format;;Target assigned is molecular non-protein target;3;PUBCHEM_BIOASSAY: C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431];CHEMBL1201862;Molecular target other than protein assigned;M;504727;7;CHEMBL612408;;
CLD0;confirmatory;;CHEMBL1738442;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404];CHEMBL1201862;Direct protein target assigned;D;504332;7;CHEMBL6032;;
CLD0;confirmatory;;CHEMBL1738444;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: ME-1 cellular proliferation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1477, AID1484];CHEMBL1201862;Direct protein target assigned;D;504370;7;CHEMBL2093862;;
CLD0;confirmatory;;CHEMBL1738498;[];Influenza A virus (A/California/07/2009(H1N1));[];;;641809.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Discovery of Small Molecule Probes for H1N1 Influenza NS1A. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504399];CHEMBL1201862;Homologous protein target assigned;H;504329;7;CHEMBL1293303;;
CLD0;confirmatory;;CHEMBL1738574;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485342, AID485388];CHEMBL1201862;Direct protein target assigned;D;493005;7;CHEMBL6157;;
CLD0;confirmatory;;CHEMBL1738606;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398];CHEMBL1201862;Direct protein target assigned;D;504327;7;CHEMBL5501;;
CLD0;confirmatory;;CHEMBL1738132;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709];CHEMBL1201862;Direct protein target assigned;D;504706;7;CHEMBL4096;;
CLD0;confirmatory;;CHEMBL1738194;[];Human herpesvirus 8;[];;;37296.0;;;B;Binding;BAO_0000217;biochemical format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431];CHEMBL1201862;Direct protein target assigned;D;504725;7;CHEMBL1741163;;
CLD0;confirmatory;;CHEMBL1738397;[];Trypanosoma brucei TREU927;[];;;185431.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485367, AID485368, AID488768];CHEMBL1201862;Homologous protein target assigned;H;492961;7;CHEMBL5686;;
CLD0;other;;CHEMBL1741321;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active;CHEMBL1201862;Homologous protein target assigned;H;1851_2;7;CHEMBL289;;
CLD0;other;;CHEMBL1741322;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active;CHEMBL1201862;Homologous protein target assigned;H;1851_4;7;CHEMBL3356;;
CLD0;other;;CHEMBL1741323;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active;CHEMBL1201862;Homologous protein target assigned;H;1851_1;7;CHEMBL3622;;
CLD0;other;;CHEMBL1741324;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active;CHEMBL1201862;Homologous protein target assigned;H;1851_3;7;CHEMBL340;;
CLD0;other;;CHEMBL1741325;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active;CHEMBL1201862;Homologous protein target assigned;H;1851_5;7;CHEMBL3397;;
CLD0;;;CHEMBL1764598;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to poly(dAT)2 assessed as change in melting temperature at compound to polynucleotide ratio of 1;CHEMBL1759981;Molecular target other than protein assigned;M;365308;1;CHEMBL613826;;
CLD0;;KB ;CHEMBL1777076;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB cells after 6 hrs by MTT assay;CHEMBL1773024;Non-molecular target assigned;N;374103;1;CHEMBL398;;
CLD0;;KB-C2;CHEMBL1777077;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human KB-C2 cells after 6 hrs by MTT assay;CHEMBL1773024;Non-molecular target assigned;N;374104;1;CHEMBL3879801;;
CLD0;;MCF7;CHEMBL1777078;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 6 hrs by MTT assay;CHEMBL1773024;Non-molecular target assigned;N;374105;1;CHEMBL387;;
CLD0;;KB-C2;CHEMBL1777079;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human colchicine-resistant KB-C2 cells after 6 hrs by MTT assay;CHEMBL1773024;Non-molecular target assigned;N;374107;1;CHEMBL3879801;;
CLD0;;K562;CHEMBL1777080;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human doxorubicin-resistant K562 cells after 6 hrs by MTT assay;CHEMBL1773024;Non-molecular target assigned;N;374108;1;CHEMBL385;;
CLD0;;K562;CHEMBL1777081;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells after 6 hrs by MTT assay;CHEMBL1773024;Non-molecular target assigned;N;374109;1;CHEMBL385;;
CLD0;confirmatory;;CHEMBL1794352;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411];CHEMBL1201862;Homologous protein target assigned;H;588342;7;CHEMBL5567;;
CLD0;confirmatory;;CHEMBL1794358;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay for activators of recombinant IDE. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588439, AID588440, AID588442];CHEMBL1201862;Homologous protein target assigned;H;588681;7;CHEMBL1293287;;
CLD0;confirmatory;;CHEMBL1794364;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of estrogen receptor alpha signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588514;7;CHEMBL206;;
CLD0;confirmatory;;CHEMBL1794371;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of retinoid X receptor alpha signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588544;7;CHEMBL2061;;
CLD0;confirmatory;HEK293;CHEMBL1794308;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249];CHEMBL1201862;Non-molecular target assigned;N;540256;7;CHEMBL614818;;
CLD0;confirmatory;;CHEMBL1794311;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855];CHEMBL1201862;Homologous protein target assigned;H;504847;7;CHEMBL1977;;
CLD0;confirmatory;;CHEMBL1794375;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278];CHEMBL1201862;Default value - Target has yet to be curated;U;540276;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1794376;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of vitamin D receptor signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588541;7;CHEMBL1977;;
CLD0;confirmatory;;CHEMBL1794382;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of glucocorticoid receptor signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588533;7;CHEMBL2034;;
CLD0;confirmatory;;CHEMBL1794399;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588547;7;CHEMBL1947;;
CLD0;confirmatory;;CHEMBL1794345;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504834;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794445;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Fluorescence polarization-based cell-based high throughput dose response assay to identify activators of insulin-degrading enzyme (IDE). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588681];CHEMBL1201862;Homologous protein target assigned;H;588439;7;CHEMBL1293287;;
CLD0;confirmatory;;CHEMBL1794467;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of USP1/UAF1: Pilot qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878];CHEMBL1201862;Homologous protein target assigned;H;504865;7;CHEMBL1795087;;
CLD0;confirmatory;;CHEMBL1794471;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588546;7;CHEMBL2061;;
CLD0;confirmatory;;CHEMBL1794483;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623];CHEMBL1201862;Homologous protein target assigned;H;588590;7;CHEMBL5391;;
CLD0;confirmatory;;CHEMBL1794499;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856];CHEMBL1201862;Homologous protein target assigned;H;504845;7;CHEMBL1795091;;
CLD0;confirmatory;;CHEMBL1794510;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588537;7;CHEMBL235;;
CLD0;confirmatory;;CHEMBL1794524;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588535;7;CHEMBL3979;;
CLD0;confirmatory;;CHEMBL1794536;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638];CHEMBL1201862;Homologous protein target assigned;H;588579;7;CHEMBL5365;;
CLD0;confirmatory;;CHEMBL1794542;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of estrogen receptor alpha signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588513;7;CHEMBL206;;
CLD0;confirmatory;HEK293;CHEMBL1794548;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Counterscreen for activators of insulin-degrading enzyme (IDE): fluorescence-based cell-based high throughput dose response LDH release assay to identify compounds that are cytotoxic to HEK cells or compromise cell membrane permeability. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588681];CHEMBL1201862;Non-molecular target assigned;N;588440;7;CHEMBL614818;;
CLD0;confirmatory;;CHEMBL1794560;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of androgen receptor signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588516;7;CHEMBL1871;;
CLD0;confirmatory;;CHEMBL1794561;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588545;7;CHEMBL1947;;
CLD0;confirmatory;HEK293;CHEMBL1794570;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay to identify fluorescent artifacts and/or optically active compounds. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588681];CHEMBL1201862;Non-molecular target assigned;N;588442;7;CHEMBL614818;;
CLD0;confirmatory;;CHEMBL1794580;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504832;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794584;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860];CHEMBL1201862;Homologous protein target assigned;H;588855;7;CHEMBL1293258;;
CLD0;confirmatory;;CHEMBL1794585;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;504891;7;CHEMBL2288;;
CLD0;;MCF7;CHEMBL1804213;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Anticancer activity against human MCF7 cells;CHEMBL1800004;Non-molecular target assigned;N;387376;1;CHEMBL387;;
CLD0;;NCI-H460;CHEMBL1804214;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Anticancer activity against human NCI-H460 cells;CHEMBL1800004;Non-molecular target assigned;N;387377;1;CHEMBL396;;
CLD0;;SF-268;CHEMBL1804215;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Anticancer activity against human SF268 cells;CHEMBL1800004;Non-molecular target assigned;N;387378;1;CHEMBL613977;;
CLD0;;MRC5;CHEMBL1804216;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308499;Target assigned is non-molecular;1;Antiproliferative activity against human MRC5 cells;CHEMBL1800004;Non-molecular target assigned;N;387383;1;CHEMBL614181;;
CLD0;;NCI-H460;CHEMBL1804223;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Selectivity index, ratio of IC50 of human MRC5 cells to IC50 for human NCI-H460 cells;CHEMBL1800004;Non-molecular target assigned;N;387379;1;CHEMBL396;;
CLD0;;MRC5;CHEMBL1804224;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308499;Target assigned is non-molecular;1;Selectivity index, ratio of IC50 of human MRC5 cells to IC50 for human MCF7 cells;CHEMBL1800004;Non-molecular target assigned;N;387381;1;CHEMBL614181;;
CLD0;;SF-268;CHEMBL1804225;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Selectivity index, ratio of IC50 of human MRC5 cells to IC50 for human SF268 cells;CHEMBL1800004;Non-molecular target assigned;N;387382;1;CHEMBL613977;;
CLD0;;;CHEMBL1908080;[];Homo sapiens;[];;;9606.0;In vitro;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Specific activity of expressed human recombinant UGT1A1;CHEMBL1907987;Direct protein target assigned;D;1;1;CHEMBL1287617;;
CLD0;;;CHEMBL1908083;[];Homo sapiens;[];;;9606.0;In vitro;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Specific activity of expressed human recombinant UGT1A6;CHEMBL1907987;Direct protein target assigned;D;4;1;CHEMBL1743316;;
CLD0;;;CHEMBL1908086;[];Homo sapiens;[];;;9606.0;In vitro;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Specific activity of expressed human recombinant UGT1A9;CHEMBL1907987;Direct protein target assigned;D;7;1;CHEMBL1743319;;
CLD0;;MDR1-MDCKII;CHEMBL1908285;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;1;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908286;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;2;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908289;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;5;1;CHEMBL4302;;
CLD0;;Sf9;CHEMBL1908291;[];Spodoptera frugiperda;[];(null);Membrane;7108.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM;CHEMBL1908284;Homologous protein target assigned;H;7;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908292;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay;CHEMBL1908284;Homologous protein target assigned;H;8;1;CHEMBL4302;;
CLD0;;;CHEMBL1909163;[];Cavia porcellus;[];;;10141.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4);CHEMBL1909046;Direct protein target assigned;D;67;15;CHEMBL1909043;CHEMBL3638235;
CLD0;;CHO-K1;CHEMBL1909164;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4);CHEMBL1909046;Homologous protein target assigned;H;68;15;CHEMBL1798;;
CLD0;;Reticulocytes;CHEMBL1909165;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid);CHEMBL1909046;Direct protein target assigned;D;69;15;CHEMBL4358;;
CLD0;;HEK293;CHEMBL1909166;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;70;15;CHEMBL4644;;
CLD0;;HEK293;CHEMBL1909167;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;71;15;CHEMBL259;;
CLD0;;HEK293;CHEMBL1909168;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;72;15;CHEMBL4608;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909169;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine);CHEMBL1909046;Homologous protein target assigned;H;73;15;CHEMBL1951;;
CLD0;;CHO-K1;CHEMBL1909170;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;74;15;CHEMBL216;;
CLD0;;CHO-K1;CHEMBL1909171;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;75;15;CHEMBL211;;
CLD0;;CHO-K1;CHEMBL1909172;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;76;15;CHEMBL245;;
CLD0;;CHO-K1;CHEMBL1909173;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;77;15;CHEMBL1821;;
CLD0;;CHO-K1;CHEMBL1909174;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;78;15;CHEMBL2035;;
CLD0;;SK-N-MC;CHEMBL1909175;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307551;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;79;15;CHEMBL4777;;
CLD0;;KAN-TS;CHEMBL1909176;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;80;15;CHEMBL4018;;
CLD0;;IMR-32;CHEMBL1909177;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307656;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine);CHEMBL1909046;Default value - Target has yet to be curated;U;81;15;CHEMBL612545;;
CLD0;;;CHEMBL1909178;[];Rattus norvegicus;[];;;10116.0;In vitro;Cerebellum;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine);CHEMBL1909046;Direct protein target assigned;D;82;15;CHEMBL3048;CHEMBL3638233;
CLD0;;;CHEMBL1909179;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine);CHEMBL1909046;Homologous protein target assigned;H;83;15;CHEMBL3464;;
CLD0;;HEK293;CHEMBL1909180;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole);CHEMBL1909046;Homologous protein target assigned;H;84;15;CHEMBL236;;
CLD0;;HEK293;CHEMBL1909181;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;85;15;CHEMBL237;;
CLD0;;CHO-K1;CHEMBL1909182;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;86;15;CHEMBL233;;
CLD0;;;CHEMBL1909183;[];Mus musculus;[];ICR;Membrane;10090.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu);CHEMBL1909046;Default value - Target has yet to be curated;U;87;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Platelet;CHEMBL1909184;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;88;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909185;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;89;15;CHEMBL612545;;
CLD0;;Platelet;CHEMBL1909186;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP);CHEMBL1909046;Direct protein target assigned;D;90;15;CHEMBL1827;;
CLD0;;Platelet;CHEMBL1909187;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF);CHEMBL1909046;Direct protein target assigned;D;91;15;CHEMBL250;;
CLD0;;NIH3T3;CHEMBL1909188;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF);CHEMBL1909046;Default value - Target has yet to be curated;U;92;15;CHEMBL612545;;
CLD0;;HIT-T15;CHEMBL1909189;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide);CHEMBL1909046;Default value - Target has yet to be curated;U;93;15;CHEMBL612545;;
CLD0;;HEK293;CHEMBL1909190;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);CHEMBL1909046;Homologous protein target assigned;H;94;15;CHEMBL240;;
CLD0;;;CHEMBL1909191;[];Bos taurus;[];;;9913.0;In vitro;Uterus;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020);CHEMBL1909046;Direct protein target assigned;D;95;15;CHEMBL1909044;CHEMBL3638197;
CLD0;;;CHEMBL1909192;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG);CHEMBL1909046;Direct protein target assigned;D;96;15;CHEMBL4074;CHEMBL3638235;
CLD0;;;CHEMBL1909193;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC);CHEMBL1909046;Homologous protein target assigned;H;97;15;CHEMBL4801;;
CLD0;;Neutrophil;CHEMBL1909194;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC);CHEMBL1909046;Direct protein target assigned;D;98;15;CHEMBL4071;;
CLD0;;Neutrophil;CHEMBL1909195;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA);CHEMBL1909046;Direct protein target assigned;D;99;15;CHEMBL248;;
CLD0;;;CHEMBL1909196;[];Homo sapiens;[];;;9606.0;In vitro;Rheumatoid synovial fibroblasts;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Direct protein target assigned;D;100;15;CHEMBL332;;
CLD0;;;CHEMBL1909197;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Homologous protein target assigned;H;101;15;CHEMBL321;;
CLD0;;Sf9;CHEMBL1909198;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone);CHEMBL1909046;Homologous protein target assigned;H;102;15;CHEMBL299;;
CLD0;;;CHEMBL1909199;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;103;15;CHEMBL3385;;
CLD0;;;CHEMBL1909200;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;104;15;CHEMBL4040;;
CLD0;;;CHEMBL1909201;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;105;15;CHEMBL260;;
CLD0;;;CHEMBL1909202;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;106;15;CHEMBL4445;;
CLD0;;Insect cells;CHEMBL1909203;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;107;15;CHEMBL203;;
CLD0;;Insect cells;CHEMBL1909204;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;108;15;CHEMBL1841;;
CLD0;;Insect cells;CHEMBL1909205;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;109;15;CHEMBL1824;;
CLD0;;Insect cells;CHEMBL1909206;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;110;15;CHEMBL258;;
CLD0;;;CHEMBL1909207;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;111;15;CHEMBL3243;;
CLD0;;;CHEMBL1909208;[];Oryctolagus cuniculus;[];New Zealand albino;Membrane;9986.0;In vitro;Urinary bladder;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;112;15;CHEMBL612545;CHEMBL3638205;
CLD0;;CHO-K1;CHEMBL1909209;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT);CHEMBL1909046;Homologous protein target assigned;H;113;15;CHEMBL273;;
CLD0;;;CHEMBL1909210;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Direct protein target assigned;D;114;15;CHEMBL3459;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909211;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin);CHEMBL1909046;Homologous protein target assigned;H;115;15;CHEMBL224;;
CLD0;;HEK293;CHEMBL1909212;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine);CHEMBL1909046;Homologous protein target assigned;H;1;15;CHEMBL220;;
CLD0;;CHO;CHEMBL1909213;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX);CHEMBL1909046;Homologous protein target assigned;H;2;15;CHEMBL226;;
CLD0;;HEK293;CHEMBL1909214;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;3;15;CHEMBL251;;
CLD0;;CHO-K1;CHEMBL1909215;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;4;15;CHEMBL256;;
CLD0;;;CHEMBL1909084;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine);CHEMBL1909046;Default value - Target has yet to be curated;U;5;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909085;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Submaxillary gland;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;6;15;CHEMBL319;CHEMBL3987361;
CLD0;;;CHEMBL1909086;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;7;15;CHEMBL315;CHEMBL3559723;
CLD0;;HEK293;CHEMBL1909087;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Homologous protein target assigned;H;8;15;CHEMBL223;;
CLD0;;Sf9;CHEMBL1909088;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912);CHEMBL1909046;Homologous protein target assigned;H;9;15;CHEMBL1867;;
CLD0;;CHO-K1;CHEMBL1909089;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine);CHEMBL1909046;Homologous protein target assigned;H;10;15;CHEMBL1942;;
CLD0;;Sf9;CHEMBL1909090;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912);CHEMBL1909046;Homologous protein target assigned;H;11;15;CHEMBL1916;;
CLD0;;CHO-K1;CHEMBL1909091;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;12;15;CHEMBL213;;
CLD0;;CHO;CHEMBL1909092;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177);CHEMBL1909046;Homologous protein target assigned;H;13;15;CHEMBL210;;
CLD0;;HEK293;CHEMBL1909093;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;14;15;CHEMBL246;;
CLD0;;MDCK;CHEMBL1909094;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308370;Homologous single protein target assigned;8;DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;15;15;CHEMBL222;;
CLD0;;;CHEMBL1909095;[];Rattus norvegicus;[];;;10116.0;In vitro;Lens of camera-type eye;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde);CHEMBL1909046;Direct protein target assigned;D;16;15;CHEMBL2622;CHEMBL3638191;
CLD0;;CHO-K1;CHEMBL1909096;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A);CHEMBL1909046;Homologous protein target assigned;H;17;15;CHEMBL4607;;
CLD0;;;CHEMBL1909097;[];Sus scrofa;[];;;9823.0;In vitro;Heart;B;Binding;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;18;15;CHEMBL612545;CHEMBL3638187;
CLD0;;;CHEMBL1909098;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Adrenal gland;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat));CHEMBL1909046;Default value - Target has yet to be curated;U;19;15;CHEMBL612545;CHEMBL3638251;
CLD0;;;CHEMBL1909099;[];Bacillus cereus;[];;;1396.0;In vitro;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin);CHEMBL1909046;Default value - Target has yet to be curated;U;20;15;CHEMBL612545;;
CLD0;;Chem-1;CHEMBL1909100;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin);CHEMBL1909046;Homologous protein target assigned;H;21;15;CHEMBL3157;;
CLD0;;T47D;CHEMBL1909101;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307606;Homologous single protein target assigned;8;DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon));CHEMBL1909046;Homologous protein target assigned;H;22;15;CHEMBL1832;;
CLD0;;;CHEMBL1909102;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem);CHEMBL1909046;Default value - Target has yet to be curated;U;23;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909103;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine);CHEMBL1909046;Default value - Target has yet to be curated;U;24;15;CHEMBL612545;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909104;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;116;15;CHEMBL1833;;
CLD0;;CHO-K1;CHEMBL1909105;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine);CHEMBL1909046;Homologous protein target assigned;H;117;15;CHEMBL225;;
CLD0;;HEK293;CHEMBL1909106;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630);CHEMBL1909046;Default value - Target has yet to be curated;U;118;15;CHEMBL612545;;
CLD0;;;CHEMBL1909107;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Striatum;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808);CHEMBL1909046;Direct protein target assigned;D;119;15;CHEMBL5017;CHEMBL3638255;
CLD0;;HeLa;CHEMBL1909108;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308376;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;120;15;CHEMBL3371;;
CLD0;;HEK293;CHEMBL1909109;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine);CHEMBL1909046;Homologous protein target assigned;H;121;15;CHEMBL228;;
CLD0;;Jurkat;CHEMBL1909110;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307526;Homologous single protein target assigned;8;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CHEMBL1909046;Homologous protein target assigned;H;122;15;CHEMBL287;;
CLD0;;;CHEMBL1909111;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil);CHEMBL1909046;Default value - Target has yet to be curated;U;123;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909112;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin);CHEMBL1909046;Default value - Target has yet to be curated;U;124;15;CHEMBL612545;CHEMBL3638188;
CLD0;;CHO;CHEMBL1909113;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P);CHEMBL1909046;Homologous protein target assigned;H;125;15;CHEMBL249;;
CLD0;;CHO;CHEMBL1909114;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968);CHEMBL1909046;Homologous protein target assigned;H;126;15;CHEMBL2327;;
CLD0;;;CHEMBL1909115;[];Escherichia coli;[];;Membrane;562.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone);CHEMBL1909046;Homologous protein target assigned;H;127;15;CHEMBL3072;;
CLD0;;Platelet;CHEMBL1909116;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2);CHEMBL1909046;Direct protein target assigned;D;128;15;CHEMBL1835;;
CLD0;;U-937;CHEMBL1909117;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha);CHEMBL1909046;Default value - Target has yet to be curated;U;129;15;CHEMBL612545;;
CLD0;;HUVEC;CHEMBL1909118;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307501;Homologous single protein target assigned;8;DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF);CHEMBL1909046;Homologous protein target assigned;H;130;15;CHEMBL1868;;
CLD0;;HT-29;CHEMBL1909119;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307768;Homologous single protein target assigned;8;DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP);CHEMBL1909046;Homologous protein target assigned;H;131;15;CHEMBL5144;;
CLD0;;HEK293;CHEMBL1909120;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr);CHEMBL1909046;Homologous protein target assigned;H;132;15;CHEMBL1889;;
CLD0;;;CHEMBL1909121;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888));CHEMBL1909046;Default value - Target has yet to be curated;U;25;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Chem-1;CHEMBL1909122;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A);CHEMBL1909046;Homologous protein target assigned;H;26;15;CHEMBL218;;
CLD0;;Erythrocyte;CHEMBL1909123;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833281;Direct single protein target assigned;9;DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA));CHEMBL1909046;Direct protein target assigned;D;27;15;CHEMBL205;;
CLD0;;CHO-K1;CHEMBL1909124;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1);CHEMBL1909046;Homologous protein target assigned;H;28;15;CHEMBL4015;;
CLD0;;Chem-1;CHEMBL1909125;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC);CHEMBL1909046;Homologous protein target assigned;H;29;15;CHEMBL2414;;
CLD0;;HEK293;CHEMBL1909126;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha);CHEMBL1909046;Homologous protein target assigned;H;30;15;CHEMBL274;;
CLD0;;;CHEMBL1909127;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR1 (IL-8A);CHEMBL1909046;Homologous protein target assigned;H;31;15;CHEMBL4029;;
CLD0;;CHO-K1;CHEMBL1909128;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8);CHEMBL1909046;Homologous protein target assigned;H;32;15;CHEMBL2434;;
CLD0;;1321-N1;CHEMBL1909129;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718);CHEMBL1909046;Homologous protein target assigned;H;33;15;CHEMBL1901;;
CLD0;;Platelet;CHEMBL1909130;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Direct protein target assigned;D;34;15;CHEMBL221;;
CLD0;;Sf21;CHEMBL1909131;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL4106362;Homologous single protein target assigned;8;DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Homologous protein target assigned;H;35;15;CHEMBL230;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909132;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;36;15;CHEMBL3356;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909133;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;37;15;CHEMBL5282;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909134;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;38;15;CHEMBL3622;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909135;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;39;15;CHEMBL3397;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909136;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;40;15;CHEMBL289;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909137;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;41;15;CHEMBL5281;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909138;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin);CHEMBL1909046;Homologous protein target assigned;H;42;15;CHEMBL340;;
CLD0;;CHO;CHEMBL1909139;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390);CHEMBL1909046;Homologous protein target assigned;H;43;15;CHEMBL2056;;
CLD0;;CHO;CHEMBL1909140;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;44;15;CHEMBL217;;
CLD0;;CHO;CHEMBL1909141;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;45;15;CHEMBL234;;
CLD0;;CHO-K1;CHEMBL1909142;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;46;15;CHEMBL219;;
CLD0;;CHO-K1;CHEMBL1909143;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;47;15;CHEMBL238;;
CLD0;;CHO-K1;CHEMBL1909144;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1);CHEMBL1909046;Homologous protein target assigned;H;48;15;CHEMBL252;;
CLD0;;Sf9;CHEMBL1909145;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;49;15;CHEMBL206;;
CLD0;;Sf9;CHEMBL1909146;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;50;15;CHEMBL242;;
CLD0;;;CHEMBL1909147;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol);CHEMBL1909046;Default value - Target has yet to be curated;U;51;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909148;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam);CHEMBL1909046;Default value - Target has yet to be curated;U;52;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909149;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB);CHEMBL1909046;Default value - Target has yet to be curated;U;53;15;CHEMBL612545;CHEMBL3559724;
CLD0;;HeLa S3;CHEMBL1909150;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3886002;Homologous single protein target assigned;8;DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone);CHEMBL1909046;Homologous protein target assigned;H;54;15;CHEMBL2034;;
CLD0;;;CHEMBL1909151;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA);CHEMBL1909046;Default value - Target has yet to be curated;U;55;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909152;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid);CHEMBL1909046;Default value - Target has yet to be curated;U;56;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909153;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653);CHEMBL1909046;Default value - Target has yet to be curated;U;57;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909154;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP);CHEMBL1909046;Default value - Target has yet to be curated;U;58;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909155;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Spinal cord;B;Binding;BAO_0000249;cell membrane format;;Multiple direct protein targets may be assigned;5;DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine);CHEMBL1909046;Direct protein target assigned;D;59;15;CHEMBL3392921;CHEMBL3638246;
CLD0;;CHO-K1;CHEMBL1909156;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine);CHEMBL1909046;Homologous protein target assigned;H;60;15;CHEMBL231;;
CLD0;;CHO-K1;CHEMBL1909157;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine);CHEMBL1909046;Homologous protein target assigned;H;61;15;CHEMBL1941;;
CLD0;;;CHEMBL1909158;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA);CHEMBL1909046;Homologous protein target assigned;H;62;15;CHEMBL402;;
CLD0;;;CHEMBL1909159;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan);CHEMBL1909046;Default value - Target has yet to be curated;U;63;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909160;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin);CHEMBL1909046;Direct protein target assigned;D;64;15;CHEMBL5486;CHEMBL3559723;
CLD0;;NIH3T3;CHEMBL1909161;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta);CHEMBL1909046;Default value - Target has yet to be curated;U;65;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909162;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4);CHEMBL1909046;Default value - Target has yet to be curated;U;66;15;CHEMBL612545;;
CLD0;;;CHEMBL1909307;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";CHEMBL1909294;Non-molecular target assigned;N;1;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909308;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";CHEMBL1909294;Non-molecular target assigned;N;2;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909309;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";CHEMBL1909294;Non-molecular target assigned;N;3;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909310;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";CHEMBL1909294;Non-molecular target assigned;N;4;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909311;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";CHEMBL1909294;Non-molecular target assigned;N;5;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909312;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";CHEMBL1909294;Non-molecular target assigned;N;6;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909313;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";CHEMBL1909294;Non-molecular target assigned;N;7;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909314;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";CHEMBL1909294;Non-molecular target assigned;N;8;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909315;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";CHEMBL1909294;Non-molecular target assigned;N;9;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909316;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";CHEMBL1909294;Non-molecular target assigned;N;10;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909317;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";CHEMBL1909294;Non-molecular target assigned;N;11;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909318;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";CHEMBL1909294;Non-molecular target assigned;N;12;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909319;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";CHEMBL1909294;Non-molecular target assigned;N;13;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909320;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";CHEMBL1909294;Non-molecular target assigned;N;14;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1954708;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to human pre-hsa-mir-155 miRNA assessed as inhibition of dicer-catalysed (33P)-labelled pre-miRNA processing at 1 mM after 1 hr by PAGE analysis;CHEMBL1949550;Molecular target other than protein assigned;M;432865;1;CHEMBL345;;
CLD0;confirmatory;Schwann;CHEMBL1964055;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624044;7;CHEMBL2007624;;
CLD0;confirmatory;;CHEMBL1963940;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Biochemical firefly luciferase enzyme assay for NPC. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624030;7;CHEMBL5567;;
CLD0;;HeLa;CHEMBL2025278;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000224;protein format;CHEMBL3308376;Multiple direct protein targets may be assigned;5;Inhibition of HDAC1/2 in human HeLa cell nuclear extract using Fluor de Lys as substrate after 15 mins by fluorometric analysis;CHEMBL2021781;Direct protein target assigned;D;445439;1;CHEMBL2111429;;
CLD0;;HeLa;CHEMBL2025279;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;CHEMBL3308376;Direct single protein target assigned;9;Inhibition of HDAC1 in human HeLa cell nuclear extract using Fluor de Lys as substrate after 15 mins by fluorometric analysis;CHEMBL2021781;Direct protein target assigned;D;445440;1;CHEMBL325;;
CLD0;;HeLa;CHEMBL2025280;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;CHEMBL3308376;Direct single protein target assigned;9;Inhibition of HDAC6 in human HeLa cell nuclear extract using Fluor de Lys as substrate after 15 mins by fluorometric analysis;CHEMBL2021781;Direct protein target assigned;D;445441;1;CHEMBL1865;;
CLD0;;HeLa;CHEMBL2025281;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;CHEMBL3308376;Direct single protein target assigned;9;Inhibition of HDAC8 in human HeLa cell nuclear extract using Fluor de Lys as substrate after 15 mins by fluorometric analysis;CHEMBL2021781;Direct protein target assigned;D;445442;1;CHEMBL3192;;
CLD0;;;CHEMBL2025734;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of Topoisomerase 2 assessed as kinetoplast DNA decatenation at 50 uM after 10 mins by electrophoretic analysis;CHEMBL2021781;Homologous protein target assigned;H;445448;1;CHEMBL1806;;
CLD0;;DU-145;CHEMBL2025735;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;Antiproliferative activity against human DU145 cells after 72 hrs by MTS assay;CHEMBL2021781;Non-molecular target assigned;N;445449;1;CHEMBL613508;;
CLD0;;SK-MES-1;CHEMBL2025736;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307450;Target assigned is non-molecular;1;Antiproliferative activity against human SKMES1 cells after 72 hrs by MTS assay;CHEMBL2021781;Non-molecular target assigned;N;445450;1;CHEMBL614923;;
CLD0;;MCF7;CHEMBL2025737;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells after 72 hrs by MTS assay;CHEMBL2021781;Non-molecular target assigned;N;445451;1;CHEMBL387;;
CLD0;;DU-145;CHEMBL2025739;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308034;Multiple direct protein targets may be assigned;5;Inhibition of HDAC in human DU145 cells assessed as upregulation of p21waf1 protein expression at 0.1 uM after 24 hrs by Western blot analysis;CHEMBL2021781;Direct protein target assigned;D;445453;1;CHEMBL2093865;;
CLD0;;DU-145;CHEMBL2025743;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308034;Multiple direct protein targets may be assigned;5;Inhibition of HDAC in human DU145 cells assessed as histone H4 acetylation after 24 hrs by Western blot analysis;CHEMBL2021781;Direct protein target assigned;D;445457;1;CHEMBL2093865;;
CLD0;;DU-145;CHEMBL2025745;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308034;Multiple direct protein targets may be assigned;5;Inhibition of HDAC in human DU145 cells assessed as histone H3 hyperacetylation at 0.1 to 0.5 uM after 24 hrs by Western blot analysis;CHEMBL2021781;Direct protein target assigned;D;445459;1;CHEMBL2093865;;
CLD0;;DU-145;CHEMBL2025747;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308034;Direct single protein target assigned;9;Inhibition of HDAC6-mediated tubulin acetylation in human DU145 cells at 90 nM after 4 hrs by Western blot analysis;CHEMBL2021781;Direct protein target assigned;D;445461;1;CHEMBL1865;;
CLD0;;DU-145;CHEMBL2025748;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308034;Direct single protein target assigned;9;Inhibition of HDAC6-mediated tubulin acetylation in human DU145 cells at 500 nM after 4 hrs by Western blot analysis;CHEMBL2021781;Direct protein target assigned;D;445462;1;CHEMBL1865;;
CLD0;;DU-145;CHEMBL2025751;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308034;Multiple direct protein targets may be assigned;5;Inhibition of HDAC in human DU145 cells assessed as upregulation of p21 expression at IC50 concentration after 4 hrs by Western blot analysis relative to control;CHEMBL2021781;Direct protein target assigned;D;445465;1;CHEMBL2093865;;
CLD0;;DU-145;CHEMBL2025752;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308034;Multiple direct protein targets may be assigned;5;Inhibition of HDAC in human DU145 cells assessed as upregulation of p21 expression at 5 times IC50 concentration after 4 hrs by Western blot analysis relative to control;CHEMBL2021781;Direct protein target assigned;D;445466;1;CHEMBL2093865;;
CLD0;;DU-145;CHEMBL2025753;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308034;Direct single protein target assigned;9;Inhibition of topoisomerase 2 in human DU145 cells assessed as stabilization of enzyme-DNA cleavage complex at 90 nM after 30 mins by immunoblot analysis;CHEMBL2021781;Direct protein target assigned;D;445467;1;CHEMBL1806;;
CLD0;;DU-145;CHEMBL2025756;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308034;Direct single protein target assigned;9;Inhibition of topoisomerase 2 in human DU145 cells assessed as stabilization of enzyme-DNA cleavage complex at 90 nM after 72 hrs by immunoblot analysis;CHEMBL2021781;Direct protein target assigned;D;445470;1;CHEMBL1806;;
CLD0;;DU-145;CHEMBL2025759;[];Homo sapiens;[];;Nucleus;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308034;Default value - Target unknown or has yet to be assigned;0;Drug uptake in human DU145 cell nucleus at 1 uM after 4 hrs by confocal microscopic analysis;CHEMBL2021781;Default value - Target has yet to be curated;U;445473;1;CHEMBL612558;;
CLD0;;DU-145;CHEMBL2025760;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308034;Default value - Target unknown or has yet to be assigned;0;Drug uptake in human DU145 cell perinuclear region at 1 uM after 4 hrs by confocal microscopic analysis;CHEMBL2021781;Default value - Target has yet to be curated;U;445474;1;CHEMBL612558;;
CLD0;;A549;CHEMBL2025763;[];Homo sapiens;[];;Nucleus;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Drug uptake in human A549 cell nucleus at 1 uM after 4 hrs by confocal microscopic analysis;CHEMBL2021781;Default value - Target has yet to be curated;U;445477;1;CHEMBL612558;;
CLD0;;A549;CHEMBL2025764;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Drug uptake in human A549 cell perinuclear region at 1 uM after 4 hrs by confocal microscopic analysis;CHEMBL2021781;Default value - Target has yet to be curated;U;445478;1;CHEMBL612558;;
CLD0;;MONO-MAC-6;CHEMBL2025143;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as cell viability at 10'-7 M after 24 hrs by cell counting method relative to untreated control;CHEMBL2021806;Non-molecular target assigned;N;446419;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025145;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-9 M after 24 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446400;1;CHEMBL2366062;;
CLD0;;MCF7;CHEMBL2025146;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytostatic activity against human MCF7 cells after 4 days by MTT assay;CHEMBL2021806;Non-molecular target assigned;N;446397;1;CHEMBL387;;
CLD0;;LNCaP;CHEMBL2025147;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307965;Target assigned is non-molecular;1;Cytostatic activity against human LNCAP cells after 4 days by MTT assay;CHEMBL2021806;Non-molecular target assigned;N;446398;1;CHEMBL612518;;
CLD0;;HT-29;CHEMBL2025148;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytostatic activity against human HT-29 cells after 4 days by MTT assay;CHEMBL2021806;Non-molecular target assigned;N;446399;1;CHEMBL384;;
CLD0;;MONO-MAC-6;CHEMBL2025149;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-9 M after 48 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446401;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025150;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-9 M after 72 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446402;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025151;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-8 M after 24 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446403;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025152;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-8 M after 48 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446404;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025153;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-8 M after 72 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446405;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025154;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-7 M after 24 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446406;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025155;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-7 M after 48 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446407;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025156;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-7 M after 72 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446408;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025157;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-6 M after 24 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446409;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025158;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-6 M after 48 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446410;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025159;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as inhibition of cell viability at 10'-6 M after 72 hrs by cell counting method;CHEMBL2021806;Non-molecular target assigned;N;446411;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025161;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as cell viability at 10'-9 to 10'-6 M after 48 hrs by cell counting method relative to untreated control;CHEMBL2021806;Non-molecular target assigned;N;446421;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025164;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Antiproliferative activity against human MONO-MAC-6 cells assessed as cell viability at 10'-9 to 10'-6 M after 72 hrs by cell counting method relative to untreated control;CHEMBL2021806;Non-molecular target assigned;N;446424;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025171;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Induction of adhesion in human MONO-MAC-6 cells at 10'-8 to 10'-6 M after 24 hrs by electrical impedence method relative to control;CHEMBL2021806;Non-molecular target assigned;N;446431;1;CHEMBL2366062;;
CLD0;;MONO-MAC-6;CHEMBL2025172;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308335;Target assigned is non-molecular;1;Induction of adhesion in human MONO-MAC-6 cells at 10'-7 M after 1.5 hrs by electrical impedence method relative to control;CHEMBL2021806;Non-molecular target assigned;N;446432;1;CHEMBL2366062;;
CLD0;;C26;CHEMBL2026062;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antitumor activity against mouse C26 cells allografted in Balb/C mouse assessed as tumor growth inhibition;CHEMBL2021806;Non-molecular target assigned;N;446787;1;CHEMBL3879801;;
CLD0;;CHO;CHEMBL2077060;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308072;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in MRP6-expressing CHO cells;CHEMBL2074285;Homologous protein target assigned;H;193;18;CHEMBL2073661;;
CLD0;;Sf9;CHEMBL2077081;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;TP_TRANSPORTER: ATP hydrolysis in membrane vesicle from BCRP-expressing Sf9 cells;CHEMBL2074508;Homologous protein target assigned;H;214;18;CHEMBL5393;;
CLD0;;;CHEMBL2077407;[];Mus musculus;[];mdr1a/1b(-/-);;10090.0;In vivo;Brain;F;Functional;BAO_0000218;organism-based format;;Multiple direct protein targets may be assigned;5;TP_TRANSPORTER: increase in brain concentration in mdr1a/1b(-/-) mouse;CHEMBL2074016;Direct protein target assigned;D;2465;18;CHEMBL2111404;CHEMBL3638188;
CLD0;;Oocyte;CHEMBL2077538;[];Xenopus laevis;[];;;8355.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308859;Homologous single protein target assigned;8;TP_TRANSPORTER: uptake in BCRP-expressing oocyte cells;CHEMBL2074207;Homologous protein target assigned;H;266;18;CHEMBL5393;;
CLD0;;SR3A;CHEMBL2077585;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of LTC4 uptake in membrane vesicles from SR3A cells;CHEMBL2073916;Homologous protein target assigned;H;316;18;CHEMBL3004;;
CLD0;;HeLa;CHEMBL2077586;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3308376;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.05 uM) in membrane vesicle from MRP1-expressing HeLa cells;CHEMBL2074383;Homologous protein target assigned;H;318;18;CHEMBL3004;;
CLD0;;MDCK;CHEMBL2076080;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308370;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport of Rhodamine 123 in the presence of Daunorubicin (Daunomycin) at a concentration of 80uM in MDR1-expressing MDCK cells;CHEMBL2074322;Homologous protein target assigned;H;2505;18;CHEMBL4302;;
CLD0;;MDCK;CHEMBL2076093;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308370;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport of Hoechst 33342 in the presence of Daunorubicin (Daunomycin) at a concentration of 80uM in MDR1-expressing MDCK cells;CHEMBL2074322;Homologous protein target assigned;H;2518;18;CHEMBL4302;;
CLD0;;LLC-PK1;CHEMBL2076689;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport (basal to apical) in MDR1-expressing LLC-PK1 cells;CHEMBL2073866;Homologous protein target assigned;H;2560;18;CHEMBL4302;;
CLD0;;LLC-PK1;CHEMBL2076854;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport (apical to basal) of Daunorubicin (Daunomycin) at a concentration of 200 nM in MDR1-expressing LLC-PK1 cells;CHEMBL2074016;Homologous protein target assigned;H;2592;18;CHEMBL4302;;
CLD0;;NIH3T3;CHEMBL2076871;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307716;Homologous single protein target assigned;8;TP_TRANSPORTER: uptake (apical to cell) in OCT2-expressing NIH3T3 cells;CHEMBL2074124;Homologous protein target assigned;H;384;18;CHEMBL1770032;;
CLD0;;HEK293;CHEMBL2077476;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;TP_TRANSPORTER: efflux in Mrp1-expressing HEK293 cells;CHEMBL2073844;Homologous protein target assigned;H;485;18;CHEMBL2532;;
CLD0;;;CHEMBL2076530;[];Nicotiana tabacum;[];(cultivar) Samsun NN;;4097.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: growth inhibition in hMRP1-expressing tobacco;CHEMBL2073829;Homologous protein target assigned;H;681;18;CHEMBL3004;;
CLD0;;LLC-PK1;CHEMBL2075196;[];;[];;Membrane;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Azidopine photoaffinity labelling (Azidopine: 0.4 uM, Daunorubicin: 400 uM) in membranes from MDR1-expressing LLC-PK1 cells;CHEMBL2073866;Homologous protein target assigned;H;2795;18;CHEMBL4302;;
CLD0;;H-4-II-E;CHEMBL2075276;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: RNase protection assay in vitro, rat hepatoma H-4-II-E cells;CHEMBL2073882;Homologous protein target assigned;H;2196;18;CHEMBL1075229;;
CLD0;;SR3A;CHEMBL2075747;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of LTC4 uptake(LTC4: 0.05 uM, Daunorubicin: 30 uM) in membrane vesicles from SR3A cells;CHEMBL2073916;Homologous protein target assigned;H;2238;18;CHEMBL3004;;
CLD0;;GLC-4/ADR;CHEMBL2076198;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3833703;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of DNP-SG uptake in membrane vesicles from GLC4/ADR cells;CHEMBL2074115;Homologous protein target assigned;H;2253;18;CHEMBL3004;;
CLD0;;MDCK-II;CHEMBL2076208;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;9;18;CHEMBL4302;;
CLD0;;Sf9;CHEMBL2076219;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;TP_TRANSPORTER: ATP hydrolysis in MDR1-expressing Sf9 cells;CHEMBL1908284;Homologous protein target assigned;H;20;18;CHEMBL4302;;
CLD0;;SK-E2;CHEMBL2076235;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibitory effect of typical BSEP inhibitors (Verapamil & Cyclosporin A) in SK-E2 cells (expressing BSEP);CHEMBL2074066;Homologous protein target assigned;H;36;18;CHEMBL6020;;
CLD0;;BTI-TN-5B1-4;CHEMBL2076251;[];;[];;Membrane fraction;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3833782;Homologous single protein target assigned;8;TP_TRANSPORTER: ATP hydrolysis in membrane fraction from High Five (BTI-TN5B1-4) cells;CHEMBL2074016;Homologous protein target assigned;H;53;18;CHEMBL4302;;
CLD0;;HEK293;CHEMBL2076257;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in MRP1-expressing HEK293 cells;CHEMBL2074511;Homologous protein target assigned;H;60;18;CHEMBL2532;;
CLD0;;MDCK;CHEMBL2076066;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308370;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Digoxin transepithelial transport (basal to apical) in MDR1-expressing MDCK cells;CHEMBL2074370;Homologous protein target assigned;H;92;18;CHEMBL4302;;
CLD0;;Caco-2;CHEMBL2078150;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Taxol transepithelial transport (basal to apical) in Caco-2 cells;CHEMBL2074126;Homologous protein target assigned;H;121;18;CHEMBL4302;;
CLD0;;GLC-4/ADR;CHEMBL2078380;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3833703;Homologous single protein target assigned;8;TP_TRANSPORTER: efflux in GLC4/ADR cells;CHEMBL2074422;Homologous protein target assigned;H;2316;18;CHEMBL3004;;
CLD0;;LLC-PK1;CHEMBL2078487;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: intracellular accumulation in Bsep-expressing LLC-PK1 cells;CHEMBL2074223;Homologous protein target assigned;H;135;18;CHEMBL2073695;;
CLD0;;;CHEMBL2078553;[];Lactococcus lactis;[];NZ9000;Membrane vesicle;1358.0;In vitro;;F;Functional;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;TP_TRANSPORTER: ATPase assay in membrane vesicle from BCRP-expressing Lactococcus lactis cells;CHEMBL2074167;Homologous protein target assigned;H;157;18;CHEMBL5393;;
CLD0;;MDCK;CHEMBL2078561;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308370;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Vinblastine transepithelial transport (basal to apical) in MRP2-expressing MDCK cells;CHEMBL2073914;Homologous protein target assigned;H;166;18;CHEMBL5748;;
CLD0;;PEAKSTABLE;CHEMBL2078574;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in MRP1-expressing PEAKSTABEL cells;CHEMBL2074335;Homologous protein target assigned;H;180;18;CHEMBL3004;;
CLD0;;LLC-PK1;CHEMBL2078578;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: intracellular accumulation in MDR1-expressing LLC-PK1 cells;CHEMBL2074223;Homologous protein target assigned;H;185;18;CHEMBL4302;;
CLD0;;;CHEMBL2091136;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human topoisomerase 2-mediated [3H]TdR-labeled catenated kinetoplast DNA decatenation after 15 to 30 mins by scintillation counting;CHEMBL2086290;Direct protein target assigned;D;470864;1;CHEMBL1806;;
CLD0;;HepG2;CHEMBL2092591;[];Homo sapiens;[];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;HARVARD: Cytotoxicity in HepG2 cell line;CHEMBL2092589;Non-molecular target assigned;N;1;19;CHEMBL395;;
CLD0;;HepG2;CHEMBL2092592;[];Plasmodium berghei;[];ANKA;;5821.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307718;Target assigned is non-molecular;1;HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells;CHEMBL2092589;Non-molecular target assigned;N;2;19;CHEMBL612653;;
CLD0;;;CHEMBL2092593;[];Plasmodium falciparum;[];3D7;;5833.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;HARVARD: Inhibition of blood stage Plasmodium falciparum 3D7 infection;CHEMBL2092589;Non-molecular target assigned;N;3;19;CHEMBL364;;
CLD0;;;CHEMBL2092594;[];Plasmodium falciparum;[];Dd2;;5833.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection;CHEMBL2092589;Non-molecular target assigned;N;4;19;CHEMBL364;;
CLD0;confirmatory;;CHEMBL2114843;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624296;7;CHEMBL1293278;;
CLD0;confirmatory;;CHEMBL2114847;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Fluorescein FP. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624160;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114849;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651777;7;CHEMBL3201;;
CLD0;confirmatory;;CHEMBL2114853;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651749;7;CHEMBL3251;;
CLD0;confirmatory;;CHEMBL2114875;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1: Hit Validation. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624308;7;CHEMBL2288;;
CLD0;confirmatory;;CHEMBL2114889;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651757;7;CHEMBL1825;;
CLD0;confirmatory;;CHEMBL2114890;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651741;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL2114895;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for small molecule activators of the p53 signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651743;7;CHEMBL4096;;
CLD0;confirmatory;;CHEMBL2114715;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: HTRF Assay. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624162;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114775;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;651820;7;CHEMBL612545;;
CLD0;confirmatory;SW480;CHEMBL2114780;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307758;Direct single protein target assigned;9;PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624297;7;CHEMBL1293278;;
CLD0;confirmatory;;CHEMBL2114782;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;651755;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114784;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651635;7;CHEMBL1795085;;
CLD0;confirmatory;;CHEMBL2114788;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624417;7;CHEMBL1784;;
CLD0;confirmatory;;CHEMBL2114796;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651768;7;CHEMBL2146312;;
CLD0;confirmatory;;CHEMBL2114824;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1: Hit Validation using Tamra Binding. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624312;7;CHEMBL2288;;
CLD0;confirmatory;;CHEMBL2114835;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651758;7;CHEMBL2157;;
CLD0;confirmatory;;CHEMBL2114840;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;651754;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651802;7;CHEMBL1741186;;
CLD0;confirmatory;;CHEMBL2114914;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Texas Red FP. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624161;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114924;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624246;7;CHEMBL1293191;;
CLD0;confirmatory;;CHEMBL2114927;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651599;7;CHEMBL6157;;
CLD0;confirmatory;;CHEMBL2114930;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651600;7;CHEMBL6157;;
CLD0;;THP-1;CHEMBL2149450;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxicity against PMA-stimulated human THP1 cells after 72 hrs by MTT assay;CHEMBL2146369;Non-molecular target assigned;N;471156;1;CHEMBL614245;;
CLD0;;;CHEMBL2149452;[];Leishmania tropica;[];;;5666.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileishmanial activity against promastigotes of multidrug-resistant Leishmania tropica after 72 hrs by MTT assay;CHEMBL2146369;Non-molecular target assigned;N;471158;1;CHEMBL612881;;
CLD0;;;CHEMBL2149453;[];Leishmania tropica;[];LRC;;5666.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileishmanial activity against promastigotes of wild type Leishmania tropica LRC after 72 hrs by MTT assay;CHEMBL2146369;Non-molecular target assigned;N;471159;1;CHEMBL612881;;
CLD0;;;CHEMBL2149456;[];Leishmania tropica;[];;;5666.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Resistance ratio of IC50 for multidrug-resistant Leishmania tropica and IC50 for wild type Leishmania tropica LRC;CHEMBL2146369;Non-molecular target assigned;N;471162;1;CHEMBL612881;;
CLD0;;;CHEMBL2162206;[];Human immunodeficiency virus 1;[];;;11676.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay;CHEMBL2157905;Direct protein target assigned;D;478375;1;CHEMBL247;;
CLD0;;;CHEMBL2166270;[];Electrophorus electricus;[];;;8005.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of electric eel AChE at 2 mg/ml by Ellman's method;CHEMBL2163249;Direct protein target assigned;D;480081;1;CHEMBL4078;;
CLD0;;;CHEMBL2166271;[];Equus caballus;[];;;9796.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of horse BChE at 2 mg/ml by Ellman's method;CHEMBL2163249;Direct protein target assigned;D;480080;1;CHEMBL5763;;
CLD0;;;CHEMBL2184160;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Activity of human AKR1A1 expressed in Escherichia coli BL21 assessed per mg protein in presence of 0.2 mM NADPH;CHEMBL2177050;Direct protein target assigned;D;487252;1;CHEMBL2246;;
CLD0;;;CHEMBL2184161;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Activity of human recombinant His6-tagged carbonyl reductase 1 expressed in Escherichia coli BL21(DE3) using menadione as substrate by Michaelis-Menten plot analysis;CHEMBL2177050;Direct protein target assigned;D;487158;1;CHEMBL5586;;
CLD0;;;CHEMBL2184164;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Activity of human carbonyl reductase 1;CHEMBL2177050;Direct protein target assigned;D;487155;1;CHEMBL5586;;
CLD0;;;CHEMBL2184165;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Ratio of Vmax to Km for human aldo-keto reductase 1A1;CHEMBL2177050;Direct protein target assigned;D;487154;1;CHEMBL2246;;
CLD0;;;CHEMBL2184166;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Ratio of Vmax to Km for human carbonyl reductase 1;CHEMBL2177050;Direct protein target assigned;D;487153;1;CHEMBL5586;;
CLD0;;;CHEMBL2213775;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as binding constant by spectrofluorimetry based McGhee von Hippel method;CHEMBL2203053;Molecular target other than protein assigned;M;498746;1;CHEMBL345;;
CLD0;;;CHEMBL3057679;[];Sus scrofa;[];;;9823.0;;Heart left ventricle;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.05 to 0.4 uM;CHEMBL3045450;Default value - Target has yet to be curated;U;520021;1;CHEMBL612558;CHEMBL3833141;
CLD0;;;CHEMBL3057680;[];Sus scrofa;[];;;9823.0;;Heart left ventricle;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.2 uM after 10 min;CHEMBL3045450;Default value - Target has yet to be curated;U;520020;1;CHEMBL612558;CHEMBL3833141;
CLD0;;;CHEMBL3057681;[];Sus scrofa;[];;;9823.0;;Heart left ventricle;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.05 uM after 30 min;CHEMBL3045450;Default value - Target has yet to be curated;U;520018;1;CHEMBL612558;CHEMBL3833141;
CLD0;;;CHEMBL3057682;[];Sus scrofa;[];;;9823.0;;Heart left ventricle;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at > 0.1 uM after 10 min;CHEMBL3045450;Default value - Target has yet to be curated;U;520016;1;CHEMBL612558;CHEMBL3833141;
CLD0;;;CHEMBL3057683;[];Sus scrofa;[];;;9823.0;;Heart left ventricle;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.2 to 1 uM;CHEMBL3045450;Default value - Target has yet to be curated;U;520015;1;CHEMBL612558;CHEMBL3833141;
CLD0;;;CHEMBL3057684;[];Sus scrofa;[];;;9823.0;;Heart left ventricle;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.4 uM in presence of Mg2+;CHEMBL3045450;Default value - Target has yet to be curated;U;520026;1;CHEMBL612558;CHEMBL3833141;
CLD0;;;CHEMBL3057685;[];Sus scrofa;[];;;9823.0;;Heart left ventricle;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as inorganic phosphorus released from protein at 0.2 uM after 1 hr;CHEMBL3045450;Default value - Target has yet to be curated;U;520025;1;CHEMBL612558;CHEMBL3833141;
CLD0;;;CHEMBL3057686;[];Sus scrofa;[];;;9823.0;;Heart left ventricle;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Sus scrofa (pig) left ventricle Ca2+-ATPase activity of cardiac myosin assessed as residual activity at 0.8 uM;CHEMBL3045450;Default value - Target has yet to be curated;U;520017;1;CHEMBL612558;CHEMBL3833141;
CLD0;;L5178Y;CHEMBL2328698;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307690;Target assigned is non-molecular;1;Ratio of IC50 for mouse L5178Y cells expressing p-gp to IC50 for mouse L5178Y cells;CHEMBL2321804;Non-molecular target assigned;N;527074;1;CHEMBL614720;;
CLD0;;L5178Y;CHEMBL2328700;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307690;Target assigned is non-molecular;1;Cytotoxicity against mouse L5178Y cells expressing p-gp after 24 hrs by MTT assay;CHEMBL2321804;Non-molecular target assigned;N;527073;1;CHEMBL614720;;
CLD0;;L5178Y;CHEMBL2328701;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307690;Target assigned is non-molecular;1;Cytotoxicity against mouse L5178Y cells after 24 hrs by MTT assay;CHEMBL2321804;Non-molecular target assigned;N;527072;1;CHEMBL614720;;
CLD0;;DA-3;CHEMBL2345812;[];Mus musculus;[];;Lysosome;10090.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cellular uptake in mouse DA-3 cell lysosome at 10 uM after 30 mins by LysoTracker green staining-based confocal microscopic analysis relative to control;CHEMBL2331546;Default value - Target has yet to be curated;U;556603;1;CHEMBL612558;;
CLD0;;DA-3;CHEMBL2345814;[];Mus musculus;[];;Nucleus;10090.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cellular uptake in mouse DA-3 cell nucleus at 10 uM after 30 mins by DRAQ5 deep red staining-based confocal microscopic analysis relative to control;CHEMBL2331546;Default value - Target has yet to be curated;U;556601;1;CHEMBL612558;;
CLD0;;;CHEMBL2345818;[];Enterobacteria phage lambda;[];;;10710.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Displacement of SYBR from phage lambda DNA by FID assay;CHEMBL2331546;Default value - Target has yet to be curated;U;556570;1;CHEMBL612545;;
CLD0;;;CHEMBL2345819;[];Enterobacteria phage lambda;[];;;10710.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Displacement of YOYO1 from phage lambda DNA by FID assay;CHEMBL2331546;Default value - Target has yet to be curated;U;556569;1;CHEMBL612545;;
CLD0;;DA-3 cell line;CHEMBL2345821;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307940;Target assigned is non-molecular;1;Cytotoxicity against mouse DA-3 cells assessed as reduction in cell viability at 20 uM after 60 mins by XTT assay;CHEMBL2331546;Non-molecular target assigned;N;556482;1;CHEMBL3879801;;
CLD0;;DA-3 cell line;CHEMBL2345823;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307940;Target assigned is non-molecular;1;Cytotoxicity against mouse DA-3 cells assessed as reduction in cell viability at 20 uM after 180 mins by XTT assay relative to control;CHEMBL2331546;Non-molecular target assigned;N;556463;1;CHEMBL3879801;;
CLD0;;ES2;CHEMBL2345824;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human ES2 cells after 24 hrs by XTT assay;CHEMBL2331546;Non-molecular target assigned;N;556460;1;CHEMBL3879801;;
CLD0;;DA-3 cell line;CHEMBL2345825;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307940;Target assigned is non-molecular;1;Cytotoxicity against mouse DA-3 cells after 24 hrs by XTT assay;CHEMBL2331546;Non-molecular target assigned;N;556459;1;CHEMBL3879801;;
CLD0;;SK-OV-3;CHEMBL2345826;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay;CHEMBL2331546;Non-molecular target assigned;N;556417;1;CHEMBL614925;;
CLD0;;MCF7;CHEMBL2345827;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay;CHEMBL2331546;Non-molecular target assigned;N;556418;1;CHEMBL387;;
CLD0;confirmatory;;CHEMBL2354209;[];;[];;;;;;F;Functional;BAO_0000217;biochemical format;;Homologous single protein target assigned;8;PubChem BioAssay. S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;687001;7;CHEMBL2362976;;
CLD0;confirmatory;;CHEMBL2354211;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;686971;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2354221;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686978;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354254;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686979;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354282;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;652106;7;CHEMBL6152;;
CLD0;confirmatory;RMG-I;CHEMBL2354301;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308778;Homologous single protein target assigned;8;PubChem BioAssay. HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;687027;7;CHEMBL2362980;;
CLD0;confirmatory;;CHEMBL2354311;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686970;7;CHEMBL2007625;;
CLD0;;;CHEMBL2390674;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Induction of tau K19 (unknown origin) disaggregation assessed as decrease in paired helical filament formation measured disassembly-inducing half maxima after 10 days by thioflavin S fluorescence assay in presence of heparin;CHEMBL2385058;Default value - Target has yet to be curated;U;571593;1;CHEMBL612545;;
CLD0;;;CHEMBL2390678;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of tau K19 (unknown origin) aggregation assessed as inhibition of paired helical filament formation after 10 days by thioflavin S fluorescence assay in presence of heparin;CHEMBL2385058;Default value - Target has yet to be curated;U;571592;1;CHEMBL612545;;
CLD0;;;CHEMBL3137722;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;1;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137723;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;2;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137724;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;3;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137725;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source];CHEMBL3137667;Non-molecular target assigned;N;4;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137726;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;5;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137727;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;6;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137728;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;7;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137729;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;8;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137730;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;9;1;CHEMBL612545;;
CLD0;;;CHEMBL3137731;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source];CHEMBL3137667;Non-molecular target assigned;N;10;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137732;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;11;1;CHEMBL612545;;
CLD0;;;CHEMBL3137733;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;12;1;CHEMBL612545;;
CLD0;;;CHEMBL3137734;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;13;1;CHEMBL612545;;
CLD0;;;CHEMBL3137735;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source];CHEMBL3137667;Non-molecular target assigned;N;14;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137736;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Animal toxicity known. [column 'TOXIC' in source];CHEMBL3137667;Non-molecular target assigned;N;15;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137737;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Presence of at least one case with successful reintroduction. [column 'REINT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;16;1;CHEMBL612545;;
CLD0;;;CHEMBL3137738;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Comments (NB not yet translated). [column 'COMMENTAIRES' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;17;1;CHEMBL612545;;
CLD0;;;CHEMBL3137739;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source];CHEMBL3137667;Non-molecular target assigned;N;18;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137740;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Proposed mechanism(s) of liver damage. [column 'MEC' in source];CHEMBL3137667;Non-molecular target assigned;N;19;1;CHEMBL3879801;CHEMBL3559723;
CLD0;confirmatory;;CHEMBL3214946;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: Confirmatory Assay for Cherry-picked Compounds..   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720497;7;CHEMBL2146312;;
CLD0;confirmatory;;CHEMBL3214953;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;743255;7;CHEMBL1795087;;
CLD0;confirmatory;;CHEMBL3215017;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720579;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215035;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of Polymerase Kappa: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720501;7;CHEMBL5365;;
CLD0;confirmatory;;CHEMBL3215038;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;743267;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215046;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720708;7;CHEMBL2029198;;
CLD0;confirmatory;;CHEMBL3215105;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of Polymerase Eta: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720502;7;CHEMBL5542;;
CLD0;confirmatory;;CHEMBL3215169;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720533;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215220;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. Dose Response Assay for Formylpeptide Receptor (FPR) Ligands and Dose Response Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;519;7;CHEMBL3359;;
CLD0;confirmatory;;CHEMBL3215236;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;PubChem BioAssay. HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Other_Dose_CherryPick_Activity_Set2. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;743395;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL3215270;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720580;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215278;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720504;7;CHEMBL3024;;
CLD0;confirmatory;;CHEMBL3215289;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720636;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL3215292;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;PubChem BioAssay. qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Molecular target other than protein assigned;M;720652;7;CHEMBL612546;;
CLD0;confirmatory;;CHEMBL3214809;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: BLM Helicase Counterscreen for WRN Inhibitors.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720503;7;CHEMBL1293237;;
CLD0;confirmatory;;CHEMBL3214810;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Fischer Rat Thyroid (FRT) Cells. Measured in Cell-Based System Using Plate Reader - 7017-02_Other_Dose_CherryPick_Activity. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;743402;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214875;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for the Inhibitors of FEN1: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720498;7;CHEMBL5027;;
CLD0;confirmatory;;CHEMBL3214913;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720532;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214963;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of Polymerase Iota: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720496;7;CHEMBL5391;;
CLD0;confirmatory;;CHEMBL3214970;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Gametocytocidal Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;743244;7;CHEMBL612545;;
CLD0;;P388;CHEMBL3232567;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.56', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.56'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 1.56 mg/kg, ip administered as qd for 1 to 9 days relative to control;CHEMBL3227991;Non-molecular target assigned;N;655701;1;CHEMBL389;;
CLD0;;P388;CHEMBL3232568;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.78', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.78'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.78 mg/kg, ip administered as qd for 1 to 9 days relative to control;CHEMBL3227991;Non-molecular target assigned;N;655702;1;CHEMBL389;;
CLD0;;P388;CHEMBL3232569;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.39', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.39'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.39 mg/kg, ip administered as qd for 1 to 9 days relative to control;CHEMBL3227991;Non-molecular target assigned;N;655704;1;CHEMBL389;;
CLD0;;P388;CHEMBL3232570;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.2'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.2 mg/kg, ip administered as qd for 1 to 9 days relative to control;CHEMBL3227991;Non-molecular target assigned;N;655705;1;CHEMBL389;;
CLD0;;P388;CHEMBL3232575;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '16.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '16.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 16 mg/kg, ip administered as single dose on day 5, 9 and 13 relative to control;CHEMBL3227991;Non-molecular target assigned;N;655716;1;CHEMBL389;;
CLD0;;P388;CHEMBL3232576;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 8 mg/kg, ip administered as single dose on day 5, 9 and 13 relative to control;CHEMBL3227991;Non-molecular target assigned;N;655717;1;CHEMBL389;;
CLD0;;P388;CHEMBL3231195;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 4 mg/kg, ip administered as single dose for every 4 days up to 13 days relative to control;CHEMBL3227991;Non-molecular target assigned;N;655719;1;CHEMBL389;;
CLD0;;P388;CHEMBL3231196;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 2 mg/kg, ip administered as single dose on day 5, 9 and 13 relative to control;CHEMBL3227991;Non-molecular target assigned;N;655720;1;CHEMBL389;;
CLD0;;;CHEMBL3231202;[];Rattus norvegicus;[];;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Cardiotoxicity in rat assessed as minimum cumulative drug dose causing electrocardiographic changes;CHEMBL3227991;Non-molecular target assigned;N;655739;1;CHEMBL376;;
CLD0;;;CHEMBL3231203;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA98;;90371.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Genotoxicity in Salmonella typhimurium TA98 assessed as number of revertants by Ames test;CHEMBL3227991;Non-molecular target assigned;N;655818;1;CHEMBL351;;
CLD0;;;CHEMBL3231205;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];908;;90371.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Genotoxicity in Salmonella typhimurium 908 assessed as number of revertants by Ames test;CHEMBL3227991;Non-molecular target assigned;N;655821;1;CHEMBL351;;
CLD0;;;CHEMBL3231208;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA98;;90371.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Genotoxicity in Salmonella typhimurium TA98 at >8 ug/plate by Ames test;CHEMBL3227991;Non-molecular target assigned;N;655824;1;CHEMBL351;;
CLD0;;;CHEMBL3231209;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA100;;90371.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Genotoxicity in Salmonella typhimurium TA100 assessed as number of revertants by Ames test;CHEMBL3227991;Non-molecular target assigned;N;655825;1;CHEMBL351;;
CLD0;;;CHEMBL3231212;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as change in melting temperature;CHEMBL3227991;Molecular target other than protein assigned;M;655833;1;CHEMBL612514;;
CLD0;;L1210;CHEMBL3231213;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of DNA synthesis in mouse L1210 cells;CHEMBL3227991;Non-molecular target assigned;N;655834;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3231214;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of RNA synthesis in mouse L1210 cells;CHEMBL3227991;Non-molecular target assigned;N;655835;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3231219;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of DNA synthesis in mouse L1210 cells;CHEMBL3227939;Non-molecular target assigned;N;655888;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3231220;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of RNA synthesis in mouse L1210 cells;CHEMBL3227939;Non-molecular target assigned;N;655889;1;CHEMBL386;;
CLD0;;P388;CHEMBL3231308;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as optimal dose;CHEMBL3227963;Non-molecular target assigned;N;655962;1;CHEMBL389;;
CLD0;;P388;CHEMBL3232181;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.9', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.9'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as average survival time at 2.9 mg/kg, ip relative to untreated control;CHEMBL3227963;Non-molecular target assigned;N;655963;1;CHEMBL389;;
CLD0;;P388;CHEMBL3232185;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.9', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.9'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse allografted with mouse P388 cells at 2.9 mg/kg, ip;CHEMBL3227963;Non-molecular target assigned;N;655967;1;CHEMBL375;;
CLD0;;P388;CHEMBL3231598;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '32.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '32.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as tumor inhibition at 32 mg/kg, ip on days 5, 9 and 13 relative to untreated control;CHEMBL3227922;Non-molecular target assigned;N;656395;1;CHEMBL389;;
CLD0;;P388;CHEMBL3231599;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '16.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '16.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as tumor inhibition at 16 mg/kg, ip on days 5, 9 and 13 relative to untreated control;CHEMBL3227922;Non-molecular target assigned;N;656396;1;CHEMBL389;;
CLD0;;P388;CHEMBL3231600;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as tumor inhibition at 8 mg/kg, ip on days 5, 9 and 13 relative to untreated control;CHEMBL3227922;Non-molecular target assigned;N;656397;1;CHEMBL389;;
CLD0;;P388;CHEMBL3231601;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as tumor inhibition at 4 mg/kg, ip on days 5, 9 and 13 relative to untreated control;CHEMBL3227922;Non-molecular target assigned;N;656398;1;CHEMBL389;;
CLD0;;P388;CHEMBL3231602;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in CDF1 mouse assessed as tumor inhibition at 2 mg/kg, ip on days 5, 9 and 13 relative to untreated control;CHEMBL3227922;Non-molecular target assigned;N;656399;1;CHEMBL389;;
CLD0;;B16;CHEMBL3231681;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in CDF1 mouse assessed as tumor inhibition at 4 mg/kg, ip on day 5 relative to untreated control;CHEMBL3227922;Non-molecular target assigned;N;656414;1;CHEMBL381;;
CLD0;;B16;CHEMBL3231682;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in CDF1 mouse assessed as tumor inhibition at 2 mg/kg, ip on day 5 relative to untreated control;CHEMBL3227922;Non-molecular target assigned;N;656415;1;CHEMBL381;;
CLD0;;B16;CHEMBL3231683;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in CDF1 mouse assessed as tumor inhibition at 1 mg/kg, ip on day 5 relative to untreated control;CHEMBL3227922;Non-molecular target assigned;N;656416;1;CHEMBL381;;
CLD0;;B16;CHEMBL3231688;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '16.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '16.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Toxicity in CDF1 mouse allografted with mouse B16 cells at 16 mg/kg, ip on day 5;CHEMBL3227922;Non-molecular target assigned;N;656444;1;CHEMBL375;;
CLD0;;P388;CHEMBL3231691;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '2-32', 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': None, 'text_value': '2-32', 'type': 'DOSE', 'units': 'mg/kg', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];CDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in CDF1 mouse allografted with mouse P388 cells assessed as survival at 2 to 32 mg/kg, ip on days 5, 9 and 13;CHEMBL3227922;Non-molecular target assigned;N;656469;1;CHEMBL375;;
CLD0;;;CHEMBL3232246;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA98;;90371.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Salmonella typhimurium TA98 assessed as growth inhibition after 1 hr;CHEMBL3227953;Non-molecular target assigned;N;655579;1;CHEMBL351;;
CLD0;;;CHEMBL3232247;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA100;;90371.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Salmonella typhimurium TA100 assessed as growth inhibition after 1 hr;CHEMBL3227953;Non-molecular target assigned;N;655580;1;CHEMBL351;;
CLD0;;;CHEMBL3232248;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA1537;;90371.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Salmonella typhimurium TA1537 assessed as growth inhibition after 1 hr;CHEMBL3227953;Non-molecular target assigned;N;655582;1;CHEMBL351;;
CLD0;;;CHEMBL3232249;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA98;;90371.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Mutagenic activity in Salmonella typhimurium TA98 assessed as mutation frequency at 10'4 times D50 after 1 hr;CHEMBL3227953;Non-molecular target assigned;N;655682;1;CHEMBL351;;
CLD0;;;CHEMBL3232250;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA100;;90371.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Mutagenic activity in Salmonella typhimurium TA100 assessed as mutation frequency at 10'4 times D50 after 1 hr;CHEMBL3227953;Non-molecular target assigned;N;655683;1;CHEMBL351;;
CLD0;;;CHEMBL3232251;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA1537;;90371.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Mutagenic activity in Salmonella typhimurium TA1537 assessed as mutation frequency at 10'4 times D50 after 1 hr;CHEMBL3227953;Non-molecular target assigned;N;655684;1;CHEMBL351;;
CLD0;;;CHEMBL3256019;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as change in melting temperature at 5 uM by spectrophotometer analysis;CHEMBL3244385;Molecular target other than protein assigned;M;668442;1;CHEMBL612514;;
CLD0;;L1210;CHEMBL3256021;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of DNA synthesis in mouse L1210 cells;CHEMBL3244385;Non-molecular target assigned;N;668498;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256022;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of RNA synthesis in mouse L1210 cells;CHEMBL3244385;Non-molecular target assigned;N;668499;1;CHEMBL386;;
CLD0;;;CHEMBL3256023;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient, log P of the compound;CHEMBL3244385;Default value - Target has yet to be curated;U;668500;1;CHEMBL2362975;;
CLD0;;P388;CHEMBL3256433;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 4 mg/kg, ip administered on days 1 to 9 relative to control;CHEMBL3244385;Non-molecular target assigned;N;668510;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256434;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 2 mg/kg, ip administered on days 1 to 9 relative to control;CHEMBL3244385;Non-molecular target assigned;N;668511;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256435;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 1 mg/kg, ip administered on days 1 to 9 relative to control;CHEMBL3244385;Non-molecular target assigned;N;668512;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256436;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 0.5 mg/kg, ip administered on days 1 to 9 relative to control;CHEMBL3244385;Non-molecular target assigned;N;668513;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256437;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 94, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Acute Graft Versus Host Disease GVHD in Rats', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antitumor activity against mouse P388 cells allografted in BDF/CDF mouse assessed as host survival time at 0.25 mg/kg, ip administered on days 1 to 9 relative to control;CHEMBL3244385;Non-molecular target assigned;N;668515;1;CHEMBL389;;
CLD0;;;CHEMBL3256439;[];Rattus norvegicus;[];;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Cardiotoxicity in rat EEG model;CHEMBL3244385;Non-molecular target assigned;N;668519;1;CHEMBL376;;
CLD0;;;CHEMBL3256440;[];Rattus norvegicus;[];;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Cardiotoxicity in rat EEG model relative to adriamycin;CHEMBL3244385;Non-molecular target assigned;N;668520;1;CHEMBL376;;
CLD0;;L1210;CHEMBL3256154;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Selectivity ratio of ED50 for inhibition of DNA synthesis in mouse L1210 cells to ED50 for inhibition of RNA synthesis in mouse L1210 cells;CHEMBL3244252;Non-molecular target assigned;N;659037;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256155;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of DNA synthesis in mouse L1210 cells;CHEMBL3244252;Non-molecular target assigned;N;659035;1;CHEMBL386;;
CLD0;;;CHEMBL3256156;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as change in melting temperature;CHEMBL3244252;Molecular target other than protein assigned;M;659034;1;CHEMBL612514;;
CLD0;;P388;CHEMBL3256157;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.78', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.78'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in CDF/BDF mouse assessed as survival time at 0.78 mg/kg, ip administered as qd for 1 to 9 days relative to control;CHEMBL3244252;Non-molecular target assigned;N;659038;1;CHEMBL389;;
CLD0;;L1210;CHEMBL3256158;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of RNA synthesis in mouse L1210 cells;CHEMBL3244252;Non-molecular target assigned;N;659036;1;CHEMBL386;;
CLD0;;P388;CHEMBL3252974;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in CDF/BDF mouse assessed as survival time at 8 mg/kg, ip administered as qd on day 5, 9, 13;CHEMBL3244252;Non-molecular target assigned;N;659050;1;CHEMBL389;;
CLD0;;;CHEMBL3252982;[];Rattus norvegicus;[];;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Cardiotoxicity in rat assessed as minimum cumulative cardiotoxic dose by Zbinden test;CHEMBL3244252;Non-molecular target assigned;N;659060;1;CHEMBL376;;
CLD0;;;CHEMBL3252983;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA98;;90371.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Mutagenicity in Salmonella typhimurium TA98 assessed as number of revertants by Ames test in presence of microsomal activation;CHEMBL3244252;Non-molecular target assigned;N;659062;1;CHEMBL351;;
CLD0;;;CHEMBL3252985;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA98;;90371.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Salmonella typhimurium TA98 assessed as concentration required to cause mortality per plate;CHEMBL3244252;Non-molecular target assigned;N;659307;1;CHEMBL351;;
CLD0;;P388;CHEMBL3252988;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.78', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.78'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.78 mg/kg, po qd administered from day 1 to day 9 relative to control;CHEMBL3244343;Non-molecular target assigned;N;664205;1;CHEMBL389;;
CLD0;;P388;CHEMBL3253422;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 2 mg/kg, po q4d administered on days 5, 9 and 13 relative to control;CHEMBL3244343;Non-molecular target assigned;N;664209;1;CHEMBL389;;
CLD0;;;CHEMBL3253426;[];Not specified;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to DNA (unknown origin) assessed as DNA interaction by measuring change in melting temperature;CHEMBL3244343;Default value - Target has yet to be curated;U;664219;1;CHEMBL612545;;
CLD0;;L1210;CHEMBL3253427;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of DNA synthesis in mouse L1210 cells assessed as inhibition of [3H]thymidine incorporation;CHEMBL3244343;Non-molecular target assigned;N;664223;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3253428;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of RNA synthesis in mouse L1210 cells assessed as inhibition of [3H]uridine incorporation;CHEMBL3244343;Non-molecular target assigned;N;664224;1;CHEMBL386;;
CLD0;;P388;CHEMBL3252590;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as minimum effective dose administered as single dose;CHEMBL3244336;Non-molecular target assigned;N;667312;1;CHEMBL389;;
CLD0;;P388;CHEMBL3253040;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells allografted ip dosed mouse assessed as maximum tolerated dose administered as single dose;CHEMBL3244336;Non-molecular target assigned;N;667314;1;CHEMBL375;;
CLD0;;P388;CHEMBL3253042;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as dose providing 40% increase in life span administered as single dose;CHEMBL3244336;Non-molecular target assigned;N;667317;1;CHEMBL389;;
CLD0;;P388;CHEMBL3253044;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000218;organism-based format;CHEMBL3308401;Default value - Target unknown or has yet to be assigned;0;Therapeutic index, ratio of MTD for mouse P388 cells allografted ip dosed mouse to MED for mouse P388 cells allografted in ip dosed mouse administered as single dose;CHEMBL3244336;Default value - Target has yet to be curated;U;667321;1;CHEMBL612558;;
CLD0;;;CHEMBL3254471;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA by spectral analysis;CHEMBL3243937;Molecular target other than protein assigned;M;668081;1;CHEMBL612514;;
CLD0;;L1210;CHEMBL3254890;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of DNA synthesis in mouse L1210 cells compound preincubated for 3 hrs followed by [3H]thymidine addition measured after 1 hr by scintillation counting;CHEMBL3243937;Non-molecular target assigned;N;668082;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3254891;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of RNA synthesis in mouse L1210 cells compound preincubated for 3 hrs followed by [3H]uridine addition measured after 1 hr by scintillation counting;CHEMBL3243937;Non-molecular target assigned;N;668083;1;CHEMBL386;;
CLD0;;P388;CHEMBL3254892;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.56', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.56'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 1.56 mg/kg, ip qd administered starting from day 1 to day 9 post challenge relative to control;CHEMBL3243937;Non-molecular target assigned;N;668084;1;CHEMBL389;;
CLD0;;P388;CHEMBL3254893;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.78', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.78'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.78 mg/kg, ip qd administered starting from day 1 to day 9 post challenge relative to control;CHEMBL3243937;Non-molecular target assigned;N;668086;1;CHEMBL389;;
CLD0;;P388;CHEMBL3258996;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.39', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.39'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.39 mg/kg, ip qd administered starting from day 1 to day 9 post challenge relative to control;CHEMBL3243937;Non-molecular target assigned;N;668087;1;CHEMBL389;;
CLD0;;P388;CHEMBL3258997;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.2'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.20 mg/kg, ip qd administered starting from day 1 to day 9 post challenge relative to control;CHEMBL3243937;Non-molecular target assigned;N;668088;1;CHEMBL389;;
CLD0;;P388;CHEMBL3259442;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '16.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '16.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 16 mg/kg, ip qd administered starting on day 5,9 and 13 post challenge relative to control;CHEMBL3243937;Non-molecular target assigned;N;668177;1;CHEMBL389;;
CLD0;;P388;CHEMBL3259443;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '8.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '8.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 8 mg/kg, ip qd administered starting on day 5,9 and 13 post challenge relative to control;CHEMBL3243937;Non-molecular target assigned;N;668178;1;CHEMBL389;;
CLD0;;P388;CHEMBL3259444;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 4 mg/kg, ip qd administered starting on day 5,9 and 13 post challenge relative to control;CHEMBL3243937;Non-molecular target assigned;N;668179;1;CHEMBL389;;
CLD0;;L1210;CHEMBL3281262;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of DNA synthesis in mouse L1210 cells assessed as inhibition of [3H]-thymidine incorporation measured per 10'6 cells at 1 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control;CHEMBL3272341;Non-molecular target assigned;N;683719;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3281263;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of DNA synthesis in mouse L1210 cells assessed as inhibition of [3H]-thymidine incorporation measured per 10'6 cells at 3 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control;CHEMBL3272341;Non-molecular target assigned;N;683720;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3281264;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of DNA synthesis in mouse L1210 cells assessed as inhibition of [3H]-thymidine incorporation measured per 10'6 cells at 5 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control;CHEMBL3272341;Non-molecular target assigned;N;683721;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3281265;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of RNA synthesis in mouse L1210 cells assessed as inhibition of [14C]-uridine incorporation measured per 10'6 cells at 1 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control;CHEMBL3272341;Non-molecular target assigned;N;683723;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3281266;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of RNA synthesis in mouse L1210 cells assessed as inhibition of [14C]-uridine incorporation measured per 10'6 cells at 3 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control;CHEMBL3272341;Non-molecular target assigned;N;683725;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3281267;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of RNA synthesis in mouse L1210 cells assessed as inhibition of [14C]-uridine incorporation measured per 10'6 cells at 5 uM pretreated for 1 hr followed by radiotracer addition measured after 1 hr by scintillation spectrometric analysis relative to control;CHEMBL3272341;Non-molecular target assigned;N;683726;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3281268;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cellular uptake in mouse L1210 cells assessed per 10'6 cells at 3 uM up to 120 mins;CHEMBL3272341;Non-molecular target assigned;N;683736;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3281269;[];Mus musculus;[];;;10090.0;;;U;Unassigned;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Ratio of inhibition of [3H]-thymidine incorporation into DNA in mouse L1210 cells to cellular uptake in mouse L1210 cells;CHEMBL3272341;Non-molecular target assigned;N;683738;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3281270;[];Mus musculus;[];;;10090.0;;;U;Unassigned;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Ratio of inhibition of [14C]-uridine incorporation into RNA in mouse L1210 cells to cellular uptake in mouse L1210 cells;CHEMBL3272341;Non-molecular target assigned;N;683739;1;CHEMBL386;;
CLD0;;;CHEMBL3280696;[];Escherichia coli;[];;;562.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Induction of Escherichia coli omega enzyme-mediated relaxation of Escherichia coli (RR1) pBR313 closed circular DNA at 40 X 10'-12 mol preincubated for 10 mins followed by enzyme-addition measured after 30 mins by agarose gel electrophoretic analysis;CHEMBL3272214;Default value - Target has yet to be curated;U;674179;1;CHEMBL612545;;
CLD0;;HeLa;CHEMBL3283126;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as cloning efficiency after 8 hrs;CHEMBL3272277;Non-molecular target assigned;N;683742;1;CHEMBL399;;
CLD0;;MEF;CHEMBL3283127;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307598;Target assigned is non-molecular;1;Antiproliferative activity against MEF after 72 hrs;CHEMBL3272277;Non-molecular target assigned;N;683745;1;CHEMBL614342;;
CLD0;;MEF;CHEMBL3283128;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307598;Target assigned is non-molecular;1;Inhibition of Murine sarcoma virus (Moloney) foci formation in MEF after 72 hrs;CHEMBL3272277;Non-molecular target assigned;N;683749;1;CHEMBL614342;;
CLD0;;Sarcoma-180;CHEMBL3283130;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 117, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Sarcoma Oncology Models', 'l3': 'Sarcoma', 'source': 'phenotype'}, {'assay_class_id': 118, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Sarcoma Oncology Models', 'l3': 'Sarcoma 180', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308362;Target assigned is non-molecular;1;Antitumor activity against mouse Sarcoma 180 cells allografted in mouse assessed as average survival time at 2 mg/kg, ip on day 1 post challenge relative to untreated control;CHEMBL3272277;Non-molecular target assigned;N;683751;1;CHEMBL614895;;
CLD0;;;CHEMBL3284954;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as increase in melting temperature at 2 x 10'-5 M by UV spectrophotometric analysis;CHEMBL3272356;Molecular target other than protein assigned;M;684263;1;CHEMBL612514;;
CLD0;;L1210;CHEMBL3284957;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of DNA synthesis in mouse L1210 cells preincubated for 3 hrs followed by [3H]-thymidine addition measured after 1 hr by scintillation spectrometric analysis;CHEMBL3272356;Non-molecular target assigned;N;684276;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3284958;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibition of RNA synthesis in mouse L1210 cells preincubated for 3 hrs followed by [3H]-uridine addition measured after 1 hr by scintillation spectrometric analysis;CHEMBL3272356;Non-molecular target assigned;N;684277;1;CHEMBL386;;
CLD0;;P388;CHEMBL3284961;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as change in survival time at 4 mg/kg, ip qd administered for 9 days relative to control;CHEMBL3272356;Non-molecular target assigned;N;684299;1;CHEMBL389;;
CLD0;;P388;CHEMBL3284962;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 2 mg/kg, ip qd administered for 9 days relative to control;CHEMBL3272356;Non-molecular target assigned;N;684301;1;CHEMBL389;;
CLD0;;P388;CHEMBL3285219;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 1 mg/kg, ip qd administered for 9 days relative to control;CHEMBL3272356;Non-molecular target assigned;N;684303;1;CHEMBL389;;
CLD0;;P388;CHEMBL3285220;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.5 mg/kg, ip qd administered for 9 days relative to control;CHEMBL3272356;Non-molecular target assigned;N;684305;1;CHEMBL389;;
CLD0;;P388;CHEMBL3285221;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.25 mg/kg, ip qd administered for 9 days relative to control;CHEMBL3272356;Non-molecular target assigned;N;684307;1;CHEMBL389;;
CLD0;;P388;CHEMBL3285222;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.12', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.12'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.12 mg/kg, ip qd administered for 9 days relative to control;CHEMBL3272356;Non-molecular target assigned;N;684310;1;CHEMBL389;;
CLD0;;P388;CHEMBL3285223;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.06', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.06'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase in survival time at 0.06 mg/kg, ip qd administered for 9 days relative to control;CHEMBL3272356;Non-molecular target assigned;N;684313;1;CHEMBL389;;
CLD0;;P388;CHEMBL3285231;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0.06-4', 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': None, 'text_value': '0.06-4', 'type': 'DOSE', 'units': 'mg/kg', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Acute toxicity in mouse allografted with mouse P388 cells assessed as survival less than 5 days at 0.06 to 4 mg/kg, ip qd;CHEMBL3272356;Non-molecular target assigned;N;684342;1;CHEMBL375;;
CLD0;;;CHEMBL3285234;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as bathochromatic shift at 1:1 to 16:1 compound to DNA ratio by UV-visible spectra analysis;CHEMBL3272356;Molecular target other than protein assigned;M;684843;1;CHEMBL612514;;
CLD0;;;CHEMBL3285236;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as decrease in absorptivity of visible maxima of compound at 1:1 to 16:1 compound to DNA ratio by UV-visible spectra analysis;CHEMBL3272356;Molecular target other than protein assigned;M;684844;1;CHEMBL612514;;
CLD0;;;CHEMBL3282668;[];Escherichia coli;[];;;562.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Escherichia coli RNA polymerase assessed as reduction in RNA transcription at compound/DNA molar ratio of 1;CHEMBL3272174;Default value - Target has yet to be curated;U;681176;1;CHEMBL612545;;
CLD0;;;CHEMBL3281963;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Dissociation constant, pKa of the compound;CHEMBL3272314;Default value - Target has yet to be curated;U;684084;1;CHEMBL2362975;;
CLD0;;;CHEMBL3282188;[];Escherichia coli;[];;;562.0;;;B;Binding;BAO_0000223;protein complex format;;Homologous protein complex subunits assigned;6;Inhibition of Escherichia coli DNA-dependent RNA polymerase assessed as [3H]UMP incorporation into RNA using calf thymus DNA at 0.12 mM by liquid scintillation counting;CHEMBL3272314;Homologous protein target assigned;H;684139;1;CHEMBL2364672;;
CLD0;;;CHEMBL3282189;[];Salmonidae;[];;;8015.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 6.2 by stop-flow technique in presence of 5 mM Na+ ionic strength;CHEMBL3272314;Default value - Target has yet to be curated;U;684211;1;CHEMBL612545;;
CLD0;;;CHEMBL3282190;[];Salmonidae;[];;;8015.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 6.2 by stop-flow technique in presence of 21 mM Na+ ionic strength;CHEMBL3272314;Default value - Target has yet to be curated;U;684212;1;CHEMBL612545;;
CLD0;;;CHEMBL3282191;[];Salmonidae;[];;;8015.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 7.8 by stop-flow technique in presence of 1 mM Na+ ionic strength;CHEMBL3272314;Default value - Target has yet to be curated;U;684214;1;CHEMBL612545;;
CLD0;;;CHEMBL3282192;[];Salmonidae;[];;;8015.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 7.8 by stop-flow technique in presence of 21 mM Na+ ionic strength;CHEMBL3272314;Default value - Target has yet to be curated;U;684215;1;CHEMBL612545;;
CLD0;;;CHEMBL3282193;[];Salmonidae;[];;;8015.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 7.8 by stop-flow technique in presence of 201 mM Na+ ionic strength;CHEMBL3272314;Default value - Target has yet to be curated;U;684216;1;CHEMBL612545;;
CLD0;;P388;CHEMBL3282194;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '0.25-10', 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': None, 'text_value': '0.25-10', 'type': 'DOSE', 'units': 'mg/kg', 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as tumor growth inhibition at 0.25 to 10 mg/kg;CHEMBL3272314;Non-molecular target assigned;N;684229;1;CHEMBL389;;
CLD0;;;CHEMBL3282195;[];Salmonidae;[];;;8015.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 7.8 by stop-flow technique in presence of 21 mM Na+ relative to pH 6.2;CHEMBL3272314;Default value - Target has yet to be curated;U;684250;1;CHEMBL612545;;
CLD0;;;CHEMBL3282196;[];Salmonidae;[];;;8015.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to salmon sperm DNA assessed as first order dissociation rate at pH 7.8 by stop-flow technique in presence of 201 mM Na+ relative to 1 mM Na+ ionic strength;CHEMBL3272314;Default value - Target has yet to be curated;U;684251;1;CHEMBL612545;;
CLD0;;;CHEMBL3282198;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Retardation factor of the compound in 10% methanol-chloroform by TLC;CHEMBL3272314;Default value - Target has yet to be curated;U;684260;1;CHEMBL2362975;;
CLD0;;NCI-H1299;CHEMBL3378947;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is non-molecular;1;Antiproliferative activity against human H1299 cells by XTT assay;CHEMBL3351563;Non-molecular target assigned;N;720681;1;CHEMBL3879801;;
CLD0;;A549;CHEMBL3378948;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells by XTT assay;CHEMBL3351563;Non-molecular target assigned;N;720682;1;CHEMBL392;;
CLD0;;MCF7;CHEMBL3378949;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells by XTT assay;CHEMBL3351563;Non-molecular target assigned;N;720683;1;CHEMBL387;;
CLD0;;MDA-MB-231;CHEMBL3378950;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Antiproliferative activity against human MDA-MB-231 cells by XTT assay;CHEMBL3351563;Non-molecular target assigned;N;720684;1;CHEMBL400;;
CLD0;;MRC5;CHEMBL3378951;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308499;Target assigned is non-molecular;1;Antiproliferative activity against human MRC5 cells by XTT assay;CHEMBL3351563;Non-molecular target assigned;N;720685;1;CHEMBL614181;;
CLD0;;;CHEMBL3367814;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];TA102;;90371.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Genotoxicity in Salmonella typhimurium TA102 at 3 ug/plate assessed as number of revertants per plate (Rvb = 301 +/- 5.2 no unit);CHEMBL3352176;Non-molecular target assigned;N;694406;1;CHEMBL351;;
CLD0;;;CHEMBL3420018;[];Not specified;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Genotoxicity in DNA (unknown origin) incubated for 24 hrs in dark condition by methyl green displacement assay;CHEMBL3414541;Default value - Target has yet to be curated;U;736430;1;CHEMBL612558;;
CLD0;;HL-60;CHEMBL3418660;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis;CHEMBL3414568;Non-molecular target assigned;N;738326;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL3418661;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Induction of apoptosis in human HL60 cells after 48 hrs by acridine orange/ethidium bromide staining-based fluorescence microscopic analysis;CHEMBL3414568;Non-molecular target assigned;N;738327;1;CHEMBL383;;
CLD0;;HL60R;CHEMBL3418662;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human HL60R cells expressing p-glycoprotein assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis;CHEMBL3414568;Non-molecular target assigned;N;738328;1;CHEMBL3879801;;
CLD0;;HL60R;CHEMBL3418663;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in human HL60R cells expressing p-glycoprotein after 48 hrs by acridine orange/ethidium bromide staining-based fluorescence microscopic analysis;CHEMBL3414568;Default value - Target has yet to be curated;U;738329;1;CHEMBL612545;;
CLD0;;K562;CHEMBL3418664;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells expressing Bcr-Abl assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis;CHEMBL3414568;Non-molecular target assigned;N;738330;1;CHEMBL385;;
CLD0;;K562;CHEMBL3418665;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Induction of apoptosis in human K562 cells expressing Bcr-Abl after 48 hrs by acridine orange/ethidium bromide staining-based fluorescence microscopic analysis;CHEMBL3414568;Non-molecular target assigned;N;738331;1;CHEMBL385;;
CLD0;;HepG2;CHEMBL3418666;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytotoxicity against human HepG2 cells assessed as growth inhibition after 48 hrs by trypan blue staining-based hemocytometric analysis;CHEMBL3414568;Non-molecular target assigned;N;738332;1;CHEMBL395;;
CLD0;;HepG2;CHEMBL3418667;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Induction of apoptosis in human HepG2 cells after 48 hrs by acridine orange/ethidium bromide staining-based fluorescence microscopic analysis;CHEMBL3414568;Non-molecular target assigned;N;738333;1;CHEMBL395;;
CLD0;;;CHEMBL3508166;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 't1/2', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 't1/2', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.2'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468087.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468087.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daunorubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daunorubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Terminal half-life of daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;183;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508168;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 't1/2', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 't1/2', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.2'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468087.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468087.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daunorubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daunorubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Terminal half-life ratio of 13-dihydrometabolite of daunorubicin to daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;185;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508177;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Volume of distribution', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Volume of distribution', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.2'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468087.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468087.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daunorubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daunorubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution of daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;194;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508186;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Plasma clearance', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma clearance', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.2'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468087.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468087.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daunorubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daunorubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Plasma clearance of daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;203;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508188;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Plasma clearance', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma clearance', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.2'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468087.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468087.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daunorubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daunorubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Plasma clearance ratio of 13-dihydrometabolite of daunorubicin to daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;205;28;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3508199;[];Canis lupus familiaris;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'AUC', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'AUC', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Pharmacokinetics', 'standard_type': 'DATASET', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Pharmacokinetics', 'type': 'DATASET', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'HPLC with fluorescence detection', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'HPLC with fluorescence detection', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg.Kg-1', 'value': '1.2'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2468087.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2468087.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daunorubicin', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daunorubicin', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'N', 'units': None, 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Dose', 'standard_type': 'NORMALISED_BY', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Dose', 'type': 'NORMALISED_BY', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'NORMALISED_TO', 'standard_type_fixed': 0, 'standard_units': 'mg.Kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'NORMALISED_TO', 'units': 'mg.Kg-1', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'STUDY_DOSING_DUR', 'standard_type_fixed': 0, 'standard_units': 'Week', 'standard_value': '4.0', 'text_value': None, 'type': 'STUDY_DOSING_DUR', 'units': 'Week', 'value': '4.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'PK-Anthra_dog', 'standard_type': 'STUDY_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'PK-Anthra_dog', 'type': 'STUDY_ID', 'units': None, 'value': None}];Beagle;;9615.0;In vivo;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;AUC of daunorubicin following intravenous daunorubicin at 1.2 mg.Kg-1 dose in dog;CHEMBL3508140;Default value - Target has yet to be curated;U;218;28;CHEMBL612558;CHEMBL3559721;
CLD0;;Caco-2;CHEMBL3529272;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis;CHEMBL3526001;Default value - Target has yet to be curated;U;651650;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529273;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis;CHEMBL3526001;Default value - Target has yet to be curated;U;651651;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529274;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis;CHEMBL3526001;Default value - Target has yet to be curated;U;651652;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529276;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651654;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529277;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651655;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529278;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651656;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529279;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651657;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529280;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651658;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529281;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651659;1;CHEMBL612558;;
CLD0;;;CHEMBL3529283;[];Mus musculus;[];;;10090.0;;Intestine;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Ratio of intestine AUC in po dosed mdr1 knock out mouse to intestine AUC in po dosed wild type mouse;CHEMBL3526001;Non-molecular target assigned;N;651661;1;CHEMBL613577;CHEMBL3638176;
CLD0;;Caco-2;CHEMBL3529284;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651662;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529285;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651663;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529286;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651664;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529287;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571;CHEMBL3526001;Default value - Target has yet to be curated;U;651665;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529288;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571;CHEMBL3526001;Default value - Target has yet to be curated;U;651666;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529289;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571;CHEMBL3526001;Default value - Target has yet to be curated;U;651667;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529291;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651773;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529292;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651774;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529293;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of BCRP inhibitor Ko143;CHEMBL3526001;Default value - Target has yet to be curated;U;651775;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529294;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571;CHEMBL3526001;Default value - Target has yet to be curated;U;651776;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529295;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571;CHEMBL3526001;Default value - Target has yet to be curated;U;651777;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529296;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 10 uM of MRP2 inhibitor MK571;CHEMBL3526001;Default value - Target has yet to be curated;U;651778;1;CHEMBL612558;;
CLD0;;;CHEMBL3527758;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction absorbed in human;CHEMBL3526001;Non-molecular target assigned;N;651649;1;CHEMBL372;;
CLD0;confirmatory;C2C12;CHEMBL3561978;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308003;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117325;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561981;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117309;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561990;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117310;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3561991;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117349;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561996;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. SW480 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117338;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562021;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. RKO viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117322;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562026;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Decreased HeLa cell count-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117347;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562027;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117332;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562033;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117308;7;CHEMBL612545;;
CLD0;confirmatory;SNU-C1;CHEMBL3562038;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308249;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. SNU-C1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117323;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562064;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117314;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562069;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Colo320 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117334;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562115;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells in S-phase-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117348;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562119;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117298;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562120;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117351;7;CHEMBL612545;;
CLD0;confirmatory;C2C12;CHEMBL3562121;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308003;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117327;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562123;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. HT-29 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117330;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562124;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. DLD-1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117352;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562130;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117339;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562136;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117304;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562139;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117350;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562144;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117316;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562146;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117305;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562152;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117312;7;CHEMBL612545;;
CLD0;;HEK293;CHEMBL3734567;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of Tet-induced Flag-tagged mouse TRPM7 expressed in HEK293 cells assessed as inhibition of channel-mediated cell death in presence of Mg2+ incubated for 24 to 48 hrs by propidium iodide uptake assay;CHEMBL3727350;Direct protein target assigned;D;811347;38;CHEMBL3714706;;
CLD0;;HEK293;CHEMBL3801376;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Cytotoxicity against HEK293 cells assessed as cell viability after 24 hrs by Alamar Blue assay;CHEMBL3797085;Non-molecular target assigned;N;825663;1;CHEMBL614818;;
1;;;CHEMBL3885882;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daily Repeat', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daily Repeat', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 50 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
2;;;CHEMBL3885883;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Single', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Single', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 10 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
914781;;NCI/ADR-RES;CHEMBL4014482;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;Growth inhibition of human MCF7/ADR cells after 48 hrs by SRB assay;CHEMBL4014272;Non-molecular target assigned;N;;1;CHEMBL614324;;
932354;;HEK293;CHEMBL4027183;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Cytotoxicity against HEK293 cells assessed as cell viability after 24 hrs by Alamar blue assay;CHEMBL4024766;Non-molecular target assigned;N;;1;CHEMBL614818;;
911630;;;CHEMBL4029349;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
911633;;;CHEMBL4029350;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
987630;;RD;CHEMBL4194063;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307547;Target assigned is non-molecular;1;Cytotoxicity in human RD cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay;CHEMBL4190345;Non-molecular target assigned;N;;1;CHEMBL614144;;
987631;;A549;CHEMBL4194064;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity in human A549 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay;CHEMBL4190345;Non-molecular target assigned;N;;1;CHEMBL392;;
987632;;;CHEMBL4194065;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity in human HCT16 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay;CHEMBL4190345;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
987633;;MCF7;CHEMBL4194066;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity in human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay;CHEMBL4190345;Non-molecular target assigned;N;;1;CHEMBL387;;
987634;;HEK293;CHEMBL4194067;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Cytotoxicity in human HEK293 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay;CHEMBL4190345;Non-molecular target assigned;N;;1;CHEMBL614818;;
1_GOR;;Vero C1008;CHEMBL4303083;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;IC50 for antiviral activity against SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).;CHEMBL4303773;Non-molecular target assigned;N;;52;CHEMBL4303835;;
2_GOR;;Vero C1008;CHEMBL4303085;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;AUC (viral infection %) for SARS-CoV-2 in the Vero E6 cell line at 48 h by immunofluorescence-based assay (detecting the viral NP protein in the nucleus of the Vero E6 cells).;CHEMBL4303773;Non-molecular target assigned;N;;52;CHEMBL4303835;;
3_GOR;;Vero C1008;CHEMBL4303086;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL4295411;Target assigned is non-molecular;1;Cytotoxicity of compound against Vero E6 cells by MTT assay.;CHEMBL4303773;Non-molecular target assigned;N;;52;CHEMBL4303840;;
4_GOR;;Vero C1008;CHEMBL4303089;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL4295411;Target assigned is non-molecular;1;AUC (cytotoxicity %) of compound against Vero E6 cells by MTT assay.;CHEMBL4303773;Non-molecular target assigned;N;;52;CHEMBL4303840;;
5_GOR;;Vero E6;CHEMBL4303091;[];;[];;;;In vitro;;T;Toxicity;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Selectivity ratio: ratio of AUC (viral infection %) of SARS-CoV-2 in the Vero E6 cell line compared to AUC (cytotoxicity %) of compound against Vero E6 cells by MTT assay.;CHEMBL4303773;Default value - Target has yet to be curated;U;;52;CHEMBL612558;;
6_GOR;;Vero C1008;CHEMBL4303092;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Overall antiviral activity against SARS-CoV-2 (isolate France/IDF0372/2020) in the Vero E6 cell line at 48 h based on three assays 1) detection of viral RNA by qRT-PCR (targeting the N-gene), 2) plaque assay using lysate 3 days after addition of compound by crystal violet staining 3) Cell viability (cytotoxicity) measuring percentage viable Vero E6 cells 48 h after compound addition by AlamarBlue assay.;CHEMBL4303773;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_ELL;;Caco-2;CHEMBL4303805;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307519;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging;CHEMBL4303101;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_HEI;;HRCE;CHEMBL4303810;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4303839;Target assigned is non-molecular;1;Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits);CHEMBL4303122;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_TOU;;Vero C1008;CHEMBL4303819;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs;CHEMBL4303097;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1125507;;U-87MG ATCC;CHEMBL4352916;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307575;Target assigned is non-molecular;1;Cytostatic activity against human U87 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL614247;;
1125514;;MCF7;CHEMBL4352917;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytostatic activity against human MCF7 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL387;;
1125517;;MDA-MB-231;CHEMBL4352918;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Cytostatic activity against human MDA-MB-231 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL400;;
1125518;;4T1;CHEMBL4352919;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307995;Target assigned is non-molecular;1;Cytostatic activity against mouse 4T1 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL612589;;
1125523;;HCT-116;CHEMBL4352920;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytostatic activity against human HCT116 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL394;;
1125524;;HT-29;CHEMBL4352921;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytostatic activity against human HT-29 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL384;;
1125525;;WiDr;CHEMBL4352922;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Cytostatic activity against human WiDr cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL614647;;
1125526;;CT26.WT;CHEMBL4352923;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513106;Target assigned is non-molecular;1;Cytostatic activity against mouse CT26.WT cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL4513123;;
1125530;;HepG2;CHEMBL4352924;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Cytostatic activity against human HepG2 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL395;;
1125531;;A549;CHEMBL4352925;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytostatic activity against human A549 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL392;;
1125532;;NCI-H1650;CHEMBL4352926;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308800;Target assigned is non-molecular;1;Cytostatic activity against human NCI-H1650 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL1075518;;
1125536;;NCI-H1975;CHEMBL4352927;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307601;Target assigned is non-molecular;1;Cytostatic activity against human NCI-H1975 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL614348;;
1125537;;A2058;CHEMBL4352928;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308030;Target assigned is non-molecular;1;Cytostatic activity against human A2058 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL613503;;
1125538;;;CHEMBL4352929;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytostatic activity against human M24 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1125539;;;CHEMBL4352930;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytostatic activity against human WM983B cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1125540;;B16;CHEMBL4352931;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308454;Target assigned is non-molecular;1;Cytostatic activity against mouse B16 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL381;;
1125554;;;CHEMBL4352932;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytostatic activity against human PE/CA-PJ15 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1125573;;;CHEMBL4352933;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytostatic activity against human PECAPJ41 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1125574;;OVCAR-3;CHEMBL4352934;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Cytostatic activity against human OVCAR3 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL614213;;
1125576;;PANC-1;CHEMBL4352935;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307545;Target assigned is non-molecular;1;Cytostatic activity against human PANC1 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL614139;;
1125577;;DU-145;CHEMBL4352936;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;Cytostatic activity against human DU145 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL613508;;
1125578;;PC-3;CHEMBL4352937;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytostatic activity against human PC3 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL390;;
1125580;;MRC5;CHEMBL4352938;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308499;Target assigned is non-molecular;1;Cytostatic activity against human MRC5 cells preincubated for 24 hrs under serum free condition followed by compound washout and further incubation for 48 hrs in presence of serum by MTT assay;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL614181;;
1125787;;HT-29;CHEMBL4352943;[];Homo sapiens;[];;Nucleus;9606.0;;;A;ADME;BAO_0000220;subcellular format;CHEMBL3307768;Default value - Target unknown or has yet to be assigned;0;Drug uptake in nucleus of human HT-29 cells assessed as increase in fluorescence at 50 uM after 90 mins by fluorescence based confocal microscopic analysis;CHEMBL4350976;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1126039;;HT-29;CHEMBL4352971;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antitumor activity against human HT-29 cells xenografted in SCID mouse assessed as tumor growth inhibition by measuring decrease in tumor weight at 1 mg/kg, ip administered once a week (on day 13 and 20) starting from 13 days post inoculation measured at day 23 post inoculation relative to control;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL384;;
1126086;;;CHEMBL4352972;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in SCID mouse xenografted with human HT-29 cells assessed as body weight loss at 1 mg/kg, ip administered once a week (on day 13 and 20) starting from 13 days post inoculation measured upto 23 days post inoculation;CHEMBL4350976;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1126130;;;CHEMBL4352975;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in SCID mouse xenografted with human HT-29 cells assessed as animal death at 1 mg/kg, ip administered once a week (on days 13 and 20) starting from 13 days post inoculation measured upto 23 days post inoculation;CHEMBL4350976;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1126146;;;CHEMBL4352980;[];Mus musculus;[];;;10090.0;;Liver;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Hepatotoxicity in SCID mouse xenografted with human HT-29 cells assessed as decrease in liver weight at 1 mg/kg, ip administered once a week (on days 13 and 20) starting from 13 days post inoculation measured at 23 days post inoculation;CHEMBL4350976;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559723;
1126152;;HT-29;CHEMBL4352982;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antitumor activity against human HT-29 cells xenografted in SCID mouse assessed as decrease in number of Ki-67 positive cells measured as proliferation index at 1 mg/kg, ip administered once a week (on days 13 and 20) starting from 13 days post inoculation measured at day 23 post inoculation by KI-67-staining based light microscopic analysis (Rvb = 100%);CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL384;;
1126206;;HT-29;CHEMBL4352988;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 119, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Xenograft Oncology Models', 'l3': 'Xenograft Models of Anti-Tumor Assays', 'source': 'phenotype'}];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antitumor activity against human HT-29 cells xenografted in NSG mouse assessed as tumor growth inhibition by measuring decrease in tumor growth at 1 mg/kg, iv administered once per week for 7 times starting from 5 days post inoculation measured at day 50 post inoculation;CHEMBL4350976;Non-molecular target assigned;N;;1;CHEMBL384;;
1094246;;A549;CHEMBL4393039;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay;CHEMBL4392829;Non-molecular target assigned;N;;1;CHEMBL392;;
1126892;;HEK293;CHEMBL4399803;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Cytotoxicity against human HEK293 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay;CHEMBL4396939;Non-molecular target assigned;N;;1;CHEMBL614818;;
1126888;;MCF7;CHEMBL4399804;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay;CHEMBL4396939;Non-molecular target assigned;N;;1;CHEMBL387;;
1126886;;HCT-116;CHEMBL4399805;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay;CHEMBL4396939;Non-molecular target assigned;N;;1;CHEMBL394;;
1126884;;RD;CHEMBL4399806;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307547;Target assigned is non-molecular;1;Antiproliferative activity against human RD cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay;CHEMBL4396939;Non-molecular target assigned;N;;1;CHEMBL614144;;
1126882;;A549;CHEMBL4399807;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay;CHEMBL4396939;Non-molecular target assigned;N;;1;CHEMBL392;;
1151803;;;CHEMBL4410668;[];Tetrahymena thermophila;[];;;5911.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to Tetrahymena thermophila telomeric 7 G-quadruplex DNA assessed as binding constant Kb1 in presence of 10 mM KCl by fluorescence spectroscopy;CHEMBL4406898;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1151804;;;CHEMBL4410669;[];Tetrahymena thermophila;[];;;5911.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to Tetrahymena thermophila telomeric 7 G-quadruplex DNA assessed as binding constant Kb2 in presence of 10 mM KCl by fluorescence spectroscopy;CHEMBL4406898;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1160271;;THP-1;CHEMBL4420581;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human THP1 (+/+) cells expressing wild type SAMHD1 to cytotoxic IC50 for human THP1 cells with CRISP/CAS9 SAMHD1 knockout;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160272;;THP-1;CHEMBL4420582;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human THP1 cells with constitutively expressing high SAMHD1 expression to cytotoxic IC50 for parental human THP1 cells expressing low SAMHD1 expression;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1085985;;4T1;CHEMBL4480802;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307995;Target assigned is non-molecular;1;Cytotoxicity against mouse 4T1 cells after 72 hrs by MTT assay;CHEMBL4480386;Non-molecular target assigned;N;;1;CHEMBL612589;;
1085986;;CT26.WT;CHEMBL4480803;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4513106;Target assigned is non-molecular;1;Cytotoxicity against mouse CT26.WT cells after 72 hrs by MTT assay;CHEMBL4480386;Non-molecular target assigned;N;;1;CHEMBL4513123;;
1085988;;;CHEMBL4480804;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for mouse CT26.WT cells to IC50 for mouse 4T1 cells;CHEMBL4480386;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1085994;;BHK-21;CHEMBL4480805;[];Mesocricetus auratus;[];;;10036.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308360;Target assigned is non-molecular;1;Cytotoxicity against BHK21 cells after 72 hrs by MTT assay;CHEMBL4480386;Non-molecular target assigned;N;;1;CHEMBL614527;;
1085996;;;CHEMBL4480806;[];;[];;;;;;U;Unassigned;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for BHK-21 cells to IC50 for mouse 4T1 cells;CHEMBL4480386;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1_KUZ;;;CHEMBL4495582;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate;CHEMBL4495564;Direct protein target assigned;D;;52;CHEMBL4523582;;
1_LEY;;Vero C1008;CHEMBL4513082;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4495565;Non-molecular target assigned;N;;52;CHEMBL4303835;;
CARE_1_ELL;;Vero C1008;CHEMBL4651403;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4651402;Non-molecular target assigned;N;;57;CHEMBL4303835;;
1316903;;;CHEMBL4813813;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of acid-mediated aggregation of TTR V30M mutant (unknown origin) expressed in Escherichia coli pretreated for 30 mins at pH 7 followed by protein dilution in acetate buffer and further incubated for 96 hrs at pH 4.6 by thioflavin-T fluorescence assay;CHEMBL4811317;Direct protein target assigned;D;;1;CHEMBL3194;;
1304878;;NCI/ADR-RES;CHEMBL4817009;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;Antiproliferative activity against human MCF7/ADR cells incubated for 48 hrs by CCK-8 assay;CHEMBL4813991;Non-molecular target assigned;N;;1;CHEMBL613829;;
1305120;;NCI/ADR-RES;CHEMBL4817018;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of P-glycoprotein in human MCF7/ADR cells assessed as reversal fold by measuring reduction in daunorubicin IC50 at 5 uM incubated for 48 hrs by CCK-8 assay;CHEMBL4813991;Direct protein target assigned;D;;1;CHEMBL4302;;
1351695;;Neonatal ventricular cardiomyocytes;CHEMBL5053580;[];Rattus norvegicus;[];;;10116.0;;;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against Wistar rat neonatal ventricular cardiomyocytes at 1.2 uM by LDH assay;CHEMBL5053483;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1350749;;HL-60;CHEMBL5053581;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antiproliferative activity against human HL-60 cells after 72 hrs by XTT assay;CHEMBL5053483;Non-molecular target assigned;N;;1;CHEMBL383;;
1423948;;;CHEMBL5113655;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of HDAC1 (unknown origin);CHEMBL5113372;Direct protein target assigned;D;;1;CHEMBL325;;
1423950;;;CHEMBL5113657;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of HDAC6 (unknown origin);CHEMBL5113372;Direct protein target assigned;D;;1;CHEMBL1865;;
1423977;;;CHEMBL5113668;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of HDAC8 (unknown origin);CHEMBL5113372;Direct protein target assigned;D;;1;CHEMBL3192;;
1423978;;DU-145;CHEMBL5113669;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;Cytotoxicity against human DU-145 cells assessed as cell growth inhibition;CHEMBL5113372;Non-molecular target assigned;N;;1;CHEMBL613508;;
1426074;;MDA-MB-231;CHEMBL5118114;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Growth inhibition of human MDA-MB-231 cells at 0.25 uM;CHEMBL5113490;Non-molecular target assigned;N;;1;CHEMBL400;;
1426075;;MDA-MB-231;CHEMBL5118115;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Growth inhibition of human MDA-MB-231 cells at 1 uM;CHEMBL5113490;Non-molecular target assigned;N;;1;CHEMBL400;;
1426076;;MDA-MB-231;CHEMBL5118116;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Growth inhibition of human MDA-MB-231 cells at 4 uM;CHEMBL5113490;Non-molecular target assigned;N;;1;CHEMBL400;;
1426084;;4T1;CHEMBL5118124;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307995;Target assigned is non-molecular;1;Growth inhibition of mouse 4T1 cells at 0.25 uM;CHEMBL5113490;Non-molecular target assigned;N;;1;CHEMBL612589;;
1426085;;4T1;CHEMBL5118125;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307995;Target assigned is non-molecular;1;Growth inhibition of mouse 4T1 cells at 0.5 uM;CHEMBL5113490;Non-molecular target assigned;N;;1;CHEMBL612589;;
1426086;;4T1;CHEMBL5118126;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307995;Target assigned is non-molecular;1;Growth inhibition of mouse 4T1 cells at 1 uM;CHEMBL5113490;Non-molecular target assigned;N;;1;CHEMBL612589;;
1426094;;MCF-10A;CHEMBL5118134;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307364;Target assigned is non-molecular;1;Cytotoxicity against human MCF-10A cells assessed as growth inhibition at 0.25 uM;CHEMBL5113490;Non-molecular target assigned;N;;1;CHEMBL614321;;
1426095;;MCF-10A;CHEMBL5118135;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307364;Target assigned is non-molecular;1;Cytotoxicity against human MCF-10A cells assessed as growth inhibition at 0.5 uM;CHEMBL5113490;Non-molecular target assigned;N;;1;CHEMBL614321;;
1448002;;HEK293;CHEMBL5153621;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 24 hrs by alamar blue assay;CHEMBL5150060;Non-molecular target assigned;N;;1;CHEMBL614818;;
